<html lang="en" class="pb-page js" data-request-id="94d6cd48a141aecc-GRU"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6cd48a141aecc-GRU">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/SInMerM-z_VObuYDMgL-7r1a_zlT5HqEDsPxdzL8-g96-OxxWFCZwfzPf93PeXpYfCFSxzwOBmOPMa4CHRURgQ=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6cd48a141aecc-GRU">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.5513188384330873"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="Specialties" content="Infectious Disease">
<meta name="articleType" content="Original Article">
<meta name="articleCategory" content="Research">
<meta name="topics" content="Viral Infections|Vaccines|Coronavirus"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2119451","title":"Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant","category":"Research","type":"Original Article","topics":"Viral Infections|Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2022-04-21T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e\n\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Viral Infections|Vaccines|Coronavirus\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2119451","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":{"type":"Visual Abstract","title":"Effectiveness of Covid-19 Vaccines against the Omicron Variant","doi":"10.1056/NEJMdo006518","issueDate":"2022-04-21T00:00Z","age":"6Months-1990","isFree":"y","topics":"Viral Infections|Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"}};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6cd48a141aecc-GRU">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant"><meta name="dc.Creator" content="Nick Andrews"><meta name="dc.Creator" content="Julia Stowe"><meta name="dc.Creator" content="Freja Kirsebom"><meta name="dc.Creator" content="Samuel Toffa"><meta name="dc.Creator" content="Tim Rickeard"><meta name="dc.Creator" content="Eileen Gallagher"><meta name="dc.Creator" content="Charlotte Gower"><meta name="dc.Creator" content="Meaghan Kall"><meta name="dc.Creator" content="Natalie Groves"><meta name="dc.Creator" content="Anne-Marie O’Connell"><meta name="dc.Creator" content="David Simons"><meta name="dc.Creator" content="Paula B. Blomquist"><meta name="dc.Creator" content="Asad Zaidi"><meta name="dc.Creator" content="Sophie Nash"><meta name="dc.Creator" content="Nurin Iwani Binti Abdul Aziz"><meta name="dc.Creator" content="Simon Thelwall"><meta name="dc.Creator" content="Gavin Dabrera"><meta name="dc.Creator" content="Richard Myers"><meta name="dc.Creator" content="Gayatri Amirthalingam"><meta name="dc.Creator" content="Saheer Gharbia"><meta name="dc.Creator" content="Jeffrey C. Barrett"><meta name="dc.Creator" content="Richard Elson"><meta name="dc.Creator" content="Shamez N. Ladhani"><meta name="dc.Creator" content="Neil Ferguson"><meta name="dc.Creator" content="Maria Zambon"><meta name="dc.Creator" content="Colin N.J. Campbell"><meta name="dc.Creator" content="Kevin Brown"><meta name="dc.Creator" content="Susan Hopkins"><meta name="dc.Creator" content="Meera Chand"><meta name="dc.Creator" content="Mary Ramsay"><meta name="dc.Creator" content="Jamie Lopez Bernal"><meta name="dc.Description" content="A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused ..."><meta name="Description" content="A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused ..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2022-04-21"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2119451"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202204213861610"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="YXQYoa2119451"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2022 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2119451">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2119451">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2119451">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM">
        <meta property="og:title" content="Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2119451">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/d2f1d981-336f-4a21-bbe3-ef0a852a2d2a/nejmoa2119451_f1.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/d2f1d981-336f-4a21-bbe3-ef0a852a2d2a/nejmoa2119451_f1.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529)
variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations
has aroused ...">
        <meta name="twitter:description" content="A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529)
variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations
has aroused ...">
    


    
    
        <meta property="og:image:width" content="2456">
    


    
    
        <meta property="og:image:height" content="3438">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2119451">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2119451">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:doi\:10.1056/NEJMoa2119451;issue:issue:doi\:10.1056/nejm_2022.386.issue-16;wgroup:string:MMS NextGen Website Group;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119451" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119451" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119451" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2119451" class="inputDoi"><input type="hidden" value="N. Andrews and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2022;386:1532-1546" class="inputCitation"><input type="hidden" value="03-02-2022" class="inputEPubDate"><input type="hidden" value="April 2022" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup modal-lg"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6cd48a141aecc-GRU"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Nick</span> <span property="familyName">Andrews</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Julia</span> <span property="familyName">Stowe</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Freja</span> <span property="familyName">Kirsebom</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Samuel</span> <span property="familyName">Toffa</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Tim</span> <span property="familyName">Rickeard</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Eileen</span> <span property="familyName">Gallagher</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Charlotte</span> <span property="familyName">Gower</span>, <span property="honorificSuffix">D.Phil.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+23</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Meaghan</span> <span property="familyName">Kall</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Natalie</span> <span property="familyName">Groves</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Anne-Marie</span> <span property="familyName">O’Connell</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">David</span> <span property="familyName">Simons</span>, <span property="honorificSuffix">M.B., B.S.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9655-1656" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-9655-1656</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Paula B.</span> <span property="familyName">Blomquist</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Asad</span> <span property="familyName">Zaidi</span>, <span property="honorificSuffix">M.Sc.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6420-2539" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-6420-2539</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Sophie</span> <span property="familyName">Nash</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Nurin</span> <span property="familyName">Iwani Binti Abdul Aziz</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Simon</span> <span property="familyName">Thelwall</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gavin</span> <span property="familyName">Dabrera</span>, <span property="honorificSuffix">M.B., B.S., F.F.P.H.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4606-5945" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-4606-5945</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Richard</span> <span property="familyName">Myers</span>, <span property="honorificSuffix">M.R.C.P.C.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gayatri</span> <span property="familyName">Amirthalingam</span>, <span property="honorificSuffix">M.F.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Saheer</span> <span property="familyName">Gharbia</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jeffrey C.</span> <span property="familyName">Barrett</span>, <span property="honorificSuffix">D.Phil.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Richard</span> <span property="familyName">Elson</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Shamez N.</span> <span property="familyName">Ladhani</span>, <span property="honorificSuffix">Ph.D., M.R.C.P.C.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Neil</span> <span property="familyName">Ferguson</span>, <span property="honorificSuffix">D.Phil.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Maria</span> <span property="familyName">Zambon</span>, <span property="honorificSuffix">Ph.D., F.R.C.Path.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Colin N.J.</span> <span property="familyName">Campbell</span>, <span property="honorificSuffix">M.P.H., F.F.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Kevin</span> <span property="familyName">Brown</span>, <span property="honorificSuffix">M.R.C.P., F.R.C.Path.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1568-683X" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1568-683X</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Susan</span> <span property="familyName">Hopkins</span>, <span property="honorificSuffix">F.R.C.P., F.F.P.H.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Meera</span> <span property="familyName">Chand</span>, <span property="honorificSuffix">M.R.C.P., F.R.C.Path.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mary</span> <span property="familyName">Ramsay</span>, <span property="honorificSuffix">M.B., B.S., F.F.P.H.</span></span></span>, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Jamie</span> <span property="familyName">Lopez Bernal</span>, <span property="honorificSuffix">Ph.D., M.B., B.S.</span></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-23</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">March 2, 2022</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2022<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">386</span></span>:<span property="pageStart">1532</span>-<span property="pageEnd">1546</span></div><div class="doi">DOI: 10.1056/NEJMoa2119451</div><div class="core-enumeration"><a href="/toc/nejm/386/16"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">386</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">16</span></span></a></div><div><a href="#tab-information">Copyright © 2022</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DNick%2BAndrews%252C%2BJulia%2BStowe%252C%2BFreja%2BKirsebom%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D16%26contentID%3D10.1056%252FNEJMoa2119451%26title%3DCovid-19%2BVaccine%2BEffectiveness%2Bagainst%2Bthe%2BOmicron%2B%2528B.1.1.529%2529%2BVariant%26publicationDate%3D04%252F21%252F2022" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2119451" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DNick%2BAndrews%252C%2BJulia%2BStowe%252C%2BFreja%2BKirsebom%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D16%26contentID%3D10.1056%252FNEJMoa2119451%26title%3DCovid-19%2BVaccine%2BEffectiveness%2Bagainst%2Bthe%2BOmicron%2B%2528B.1.1.529%2529%2BVariant%26publicationDate%3D04%252F21%252F2022" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/edcd1467-7926-465b-b1ff-0ffe16347a86/nejmoa2119451.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2119451.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2119451" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2119451" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119451.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current vaccines.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We used a test-negative case–control design to estimate vaccine effectiveness against symptomatic disease caused by the omicron and delta (B.1.617.2) variants in England. Vaccine effectiveness was calculated after primary immunization with two doses of BNT162b2 (Pfizer–BioNTech), ChAdOx1 nCoV-19 (AstraZeneca), or mRNA-1273 (Moderna) vaccine and after a booster dose of BNT162b2, ChAdOx1 nCoV-19, or mRNA-1273.</div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Between November 27, 2021, and January 12, 2022, a total of 886,774 eligible persons infected with the omicron variant, 204,154 eligible persons infected with the delta variant, and 1,572,621 eligible test-negative controls were identified. At all time points investigated and for all combinations of primary course and booster vaccines, vaccine effectiveness against symptomatic disease was higher for the delta variant than for the omicron variant. No effect against the omicron variant was noted from 20 weeks after two ChAdOx1 nCoV-19 doses, whereas vaccine effectiveness after two BNT162b2 doses was 65.5% (95% confidence interval [CI], 63.9 to 67.0) at 2 to 4 weeks, dropping to 8.8% (95% CI, 7.0 to 10.5) at 25 or more weeks. Among ChAdOx1 nCoV-19 primary course recipients, vaccine effectiveness increased to 62.4% (95% CI, 61.8 to 63.0) at 2 to 4 weeks after a BNT162b2 booster before decreasing to 39.6% (95% CI, 38.0 to 41.1) at 10 or more weeks. Among BNT162b2 primary course recipients, vaccine effectiveness increased to 67.2% (95% CI, 66.5 to 67.8) at 2 to 4 weeks after a BNT162b2 booster before declining to 45.7% (95% CI, 44.7 to 46.7) at 10 or more weeks. Vaccine effectiveness after a ChAdOx1 nCoV-19 primary course increased to 70.1% (95% CI, 69.5 to 70.7) at 2 to 4 weeks after an mRNA-1273 booster and decreased to 60.9% (95% CI, 59.7 to 62.1) at 5 to 9 weeks. After a BNT162b2 primary course, the mRNA-1273 booster increased vaccine effectiveness to 73.9% (95% CI, 73.1 to 74.6) at 2 to 4 weeks; vaccine effectiveness fell to 64.4% (95% CI, 62.6 to 66.1) at 5 to 9 weeks.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">Primary immunization with two doses of ChAdOx1 nCoV-19 or BNT162b2 vaccine provided limited protection against symptomatic disease caused by the omicron variant. A BNT162b2 or mRNA-1273 booster after either the ChAdOx1 nCoV-19 or BNT162b2 primary course substantially increased protection, but that protection waned over time. (Funded by the U.K. Health Security Agency.)</div></section></section><div class="core-digital-object visual-abstract">
<div class="ng-page_separator pt-24"></div>
<div class="ng-do-media">
    <button data-toggle="modal" data-target="#doPopup" class="ng-do-media_btn" modal-size="lg"></button>
    <div data-ajaxurl="/do/10.1056/NEJMdo006518/full/?ajaxRequest=true" class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="#" class="ng-do-media_item-img-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006518" data-multimedia-filename="NEJMdo006518_600x400.jpg">
                <img src="/cms/asset/0802cec2-0d58-4712-ad03-6561cc05249b/media/NEJMdo006518_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-visual"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="/browse/nejm-media-type/visual-abstract" class="ng-do-media_item-type-link">Visual Abstract</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="#" class="ng-do-media_item-title-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006518" data-multimedia-filename="NEJMdo006518_600x400.jpg">Effectiveness of Covid-19 Vaccines against the Omicron Variant</a>
            </h6>
        </div>
    </div>
</div>

</div></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">On November 26, 2021, the World Health Organization Technical Advisory Group on SARS-CoV-2 Virus Evolution named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, first detected in Botswana and South Africa, as the omicron variant of concern.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1" href-manipulated="true" aria-label="Reference 1">1</a></sup> This classification was based on a rapid increase in confirmed cases of SARS-CoV-2 infection in South Africa, coinciding with an increase in detections of the omicron variant, identification of a number of worrisome mutations, and early evidence of an increased risk of reinfection among recently infected persons.</div><div role="paragraph">A large number of mutations have been identified in the omicron variant, including multiple mutations in the receptor-binding domain of the spike protein that have been associated with increased transmissibility and immune evasion after natural infection and vaccination.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2" href-manipulated="true" aria-label="Reference 2">2</a></sup> Emerging laboratory data indicate a substantially reduced neutralizing antibody response to the omicron variant as compared with the original strain of SARS-CoV-2 or the delta (B.1.617.2) variant in vaccinated persons, although booster doses improved neutralizing activity.<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3 r4 r5" id="body-ref-r5-1" href-manipulated="true">3-5</a></sup> Neutralizing antibodies correlate with protection against reinfection and vaccine effectiveness against infection; therefore, reduced vaccine effectiveness against the omicron variant is anticipated on the basis of these early laboratory findings.<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6 r7 r8" id="body-ref-r8" href-manipulated="true">6-8</a></sup></div><div role="paragraph">Coronavirus disease 2019 (Covid-19) vaccines are highly effective against symptomatic disease and, more so, against severe disease and fatal outcomes caused by the original strain of SARS-CoV-2 as well as the alpha (B.1.1.7) variant that predominated in early 2021.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9 r10 r11 r12 r13 r14 r15" id="body-ref-r15" href-manipulated="true">9-15</a></sup> Modest reductions in vaccine effectiveness against infection and mild disease have been observed with the beta (B.1.351) and delta variants, although effectiveness against severe disease has remained high for at least 6 months after primary immunization with two Covid-19 vaccine doses.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16 r17 r18 r19" id="body-ref-r19-1" href-manipulated="true">16-19</a></sup> Waning of protection has been observed with time since vaccination, especially with the delta variant, which is able to at least partially evade natural and vaccine-induced immunity.<sup><a href="#core-r20" role="doc-biblioref" data-xml-rid="r20" id="body-ref-r20" href-manipulated="true" aria-label="Reference 20">20</a></sup> However, third (booster) doses provide a rapid and substantial increase in protection against both mild and severe disease.<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19 r21 r22 r23 r24 r25" id="body-ref-r25" href-manipulated="true">19,21–25</a></sup></div><div role="paragraph">In the United Kingdom, cases of infection with the omicron variant were first identified in mid-November 2021 through whole-genome sequencing of polymerase-chain-reaction (PCR)–positive swab samples. Initially, cases occurred primarily in travelers and their close contacts, but community transmission was apparent beginning in late November.<sup><a href="#core-r26" role="doc-biblioref" data-xml-rid="r26" id="body-ref-r26-1" href-manipulated="true" aria-label="Reference 26">26</a></sup> The U.K. Covid-19 vaccination program has been in place since December 2020 with primary courses of two doses of BNT162b2 (Comirnaty, Pfizer–BioNTech), ChAdOx1 nCoV-19 (Vaxzevria, AstraZeneca), or mRNA-1273 (Spikevax, Moderna) vaccine. Two-dose vaccine uptake is more than 60% in all cohorts of persons who are 20 years of age or older and more than 80% in all cohorts of persons who are 50 years of age or older, with vaccinations now being offered to children 12 years of age or older.<sup><a href="#core-r27" role="doc-biblioref" data-xml-rid="r27" id="body-ref-r27" href-manipulated="true" aria-label="Reference 27">27</a></sup> Booster vaccination with either BNT162b2 vaccine or a half dose (50 μg) of mRNA-1273 vaccine was introduced in September 2021 to adults 50 years of age or older and those in at-risk groups and was expanded in November 2021 to all adults. Initially, boosters were offered 6 months after completion of the primary course. With the emergence of the omicron variant in late November 2021, this interval was reduced to 3 months.<sup><a href="#core-r28" role="doc-biblioref" data-xml-rid="r28" id="body-ref-r28" href-manipulated="true" aria-label="Reference 28">28</a></sup></div><div role="paragraph">In this study, we estimated vaccine effectiveness against symptomatic disease caused by the delta and omicron variants after two doses (primary immunization) of BNT162b2, mRNA-1273, or ChAdOx1 nCoV-19 vaccine and after homologous or heterologous booster doses with the same three vaccines.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Study Design</h3><div role="paragraph">We used a test-negative case–control design to estimate vaccine effectiveness against symptomatic Covid-19 caused by the omicron variant as compared with the delta variant in persons 18 years of age or older.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17" id="body-ref-r17-2" href-manipulated="true" aria-label="Reference 17">17</a></sup> The odds of vaccination in persons with symptomatic, PCR-positive cases of SARS-CoV-2 infection were compared with those in symptomatic persons who tested negative for SARS-CoV-2 in England.</div></section><section id="sec-1-2"><h3>Data Sources</h3><section id="sec-1-2-1"><h4>Covid-19 Testing Data</h4><div role="paragraph">PCR testing for SARS-CoV-2 in England is undertaken by hospital and public health laboratories (Pillar 1) as well as by community testing (Pillar 2). Pillar 2 testing is available to anyone with symptoms consistent with Covid-19 (high temperature, new continuous cough, or loss or change in sense of smell or taste), anyone who is a contact of a person with a confirmed case, care home staff and residents, and persons with a positive rapid lateral-flow antigen test. Lateral-flow tests are freely available to all members of the population for regular home testing. Data on all positive PCR and lateral-flow tests, and on negative Pillar 2 PCR tests from persons with a date of onset of Covid-19 symptoms after November 25, 2020, were extracted up to January 12, 2022 (Fig. S1 in the <a href="#ap1">Supplementary Appendix</a>, available with the full text of this article at NEJM.org). Persons who reported symptoms and were tested in Pillar 2 between November 27, 2021, and January 12, 2022, were included in the analysis.</div><div role="paragraph">Any negative tests taken within 7 days after a previous negative test, and any negative tests for which the symptom-onset date was within the 10 days after a previous symptom-onset date for a negative test, were dropped because these probably represented the same episode. Negative tests taken within 21 days before a subsequent positive test were also excluded because chances were high that these were false negatives. Positive and negative tests within 90 days after a previous positive test were also excluded; however, when participants had later positive tests within 14 days after a positive test, preference was given to PCR tests and tests from symptomatic persons. For persons who had more than one negative test, one test was selected at random in the study period. Data were restricted to persons who had reported symptoms and gave a symptom-onset date within the 10 days before testing to account for reduced PCR sensitivity beyond this period in an infection event. Only positive tests with sequencing or genotyping information or information on spike gene (<i>S</i>) target–negative status (indicative of probable omicron infection) were included in the final analysis. A small number of positive tests were excluded when sequencing showed neither the delta nor the omicron variant. Finally, only samples obtained on November 27, 2021, or after were retained for analysis because this corresponded to the period when <i>S</i> target–negative status was predictive of the omicron variant.</div></section><section id="sec-1-2-2"><h4>Vaccination Data</h4><div role="paragraph">The National Immunization Management System (NIMS) contains demographic information on all persons residing in England who are registered with a general practice physician in that country and is used to record all Covid-19 vaccinations.<sup><a href="#core-r29" role="doc-biblioref" data-xml-rid="r29" id="body-ref-r29" href-manipulated="true" aria-label="Reference 29">29</a></sup> The NIMS was accessed on January 18, 2022, for dates of vaccination and vaccine manufacturer, sex, date of birth, race or ethnic group, and residential address. Addresses were used to determine the index of multiple deprivation (a national indication of level of deprivation that is based on small geographic areas of residence, assessed in quintiles) and were also linked to Care Quality Commission–registered care homes with the use of the unique property-reference number. Data on geographic region (NHS region), clinical risk-group status, status of being in a clinically extremely vulnerable group, and health and social care worker status were also extracted from the NIMS. Clinical risk groups included a range of chronic conditions as described in the Green Book,<sup><a href="#core-r30" role="doc-biblioref" data-xml-rid="r30" id="body-ref-r30" href-manipulated="true" aria-label="Reference 30">30</a></sup> whereas the clinically extremely vulnerable group included persons who were considered to be at the highest risk for severe Covid-19, including those with immunosuppressed conditions and those with severe respiratory disease.<sup><a href="#core-r31" role="doc-biblioref" data-xml-rid="r31" id="body-ref-r31" href-manipulated="true" aria-label="Reference 31">31</a></sup> Booster doses were identified as a third dose given at least 175 days after a second dose and administered after September 13, 2021. Persons with four or more doses of vaccine, a heterologous primary schedule, or fewer than 19 days between their first dose and second dose were excluded.</div></section><section id="sec-1-2-3"><h4>Identification of Variants and Assignment to Cases</h4><div role="paragraph">Sequencing of PCR-positive samples was undertaken through a network of laboratories, including the Wellcome Sanger Institute. Whole-genome sequences were assigned to U.K. Health Security Agency definitions of variants on the basis of mutations.<sup><a href="#core-r32" role="doc-biblioref" data-xml-rid="r32 r33" id="body-ref-r33" href-manipulated="true">32,33</a></sup> <i>S</i> target status on PCR testing is an alternative approach for identifying each variant because the omicron variant has been associated with <i>S</i> target–negative results on PCR testing with the TaqPath assay, whereas the delta variant almost always has an <i>S</i> target–positive result.<sup><a href="#core-r26" role="doc-biblioref" data-xml-rid="r26" id="body-ref-r26-2" href-manipulated="true" aria-label="Reference 26">26</a></sup> Approximately 40% of Pillar 2 community testing in England is carried out by laboratories using the TaqPath assay (Thermo Fisher Scientific). Cases were defined as being due to the delta or omicron variant on the basis of whole-genome sequencing, genotyping, or <i>S</i> target status, with sequencing taking priority, followed by genotyping. When subsequent positive tests within 14 days included sequencing or genotyping information or information on <i>S</i> target–negative status, this information was used to classify the variant. A priori, we considered that <i>S</i> target–negative status would be used to define the omicron variant when the variant accounted for at least 80% of <i>S</i> target–negative cases. Beginning on January 10, 2022, delta cases were identified by sequencing and genotyping only because the positive predictive value of <i>S</i> target–negative status to identify the delta variant had decreased and could no longer be used.</div><div role="paragraph">Testing data were linked to the NIMS on January 18, 2021, through combinations of the unique individual NHS number, date of birth, surname, first name, and postal code with the use of deterministic linkage. A total of 91.8% of eligible tests could be linked to the NIMS.</div></section></section><section id="sec-1-3"><h3>Statistical Analysis</h3><div role="paragraph">Logistic regression was used, with the PCR test result as the dependent variable and case participants being those testing positive (stratified in separate analyses as being infected with either the omicron or delta variant) and controls being those testing negative. Vaccination status was included as an independent variable, and effectiveness was defined as 1 minus the odds of vaccination in case participants, divided by the odds of vaccination in controls.</div><div role="paragraph">Vaccine effectiveness was adjusted in logistic-regression models for age (18 to 89 years in 5-year bands, then everyone ≥90 years), sex, index of multiple deprivation (quintile), race or ethnic group, history of foreign travel, geographic region, period (day of test), health and social care worker status, clinical risk-group status, status of being in a clinically extremely vulnerable group, and previously testing positive. These factors were all considered potential confounders and so were included in all models.</div><div role="paragraph">Analyses were stratified according to primary immunization course (ChAdOx1 nCoV-19, BNT162b2, or mRNA-1273 vaccine). Any heterologous primary schedules were excluded.</div><div role="paragraph">Vaccine effectiveness was assessed for each primary course in intervals of 2 to 4, 5 to 9, 10 to 14, 15 to 19, 20 to 24, and 25 or more weeks after the second dose. Vaccine effectiveness was assessed at 2 to 4, 5 to 9, and 10 or more weeks after a BNT162b2 or mRNA-1273 booster after a ChAdOx1 nCoV-19 or BNT162b2 primary course. In addition, the ChAdOx1 nCoV-19 booster was assessed after a ChAdOx1 nCoV-19 primary course in these postvaccination intervals. In persons with an mRNA-1273 primary course, vaccine effectiveness was assessed after BNT162b2 or mRNA-1273 booster vaccines after 1 week and after 2 to 4 weeks.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Descriptive Characteristics</h3><div role="paragraph">Within sequenced cases from Pillar 2 testing for which <i>S</i> target testing was performed, the percentage of <i>S</i> target–negative tests that were sequenced as the omicron variant was 50% (6 of 12) on November 25, 2021; 65% (13 of 20) on November 26; 90% (18 of 20) on November 27; 91% (10 of 11) on November 28; and 89% (17 of 19) on November 29. We therefore used cases tested on or after November 27, when the positive predictive value was more than 80%.</div><div role="paragraph">A total of 886,774 persons with symptomatic disease who were infected with the omicron variant were identified during the study period by sequencing or genotyping or by <i>S</i> target–negative status, and their tests were linked to the NIMS for vaccination status. During the same period, 204,154 eligible persons infected with the delta variant and 1,572,621 eligible test-negative controls were identified (Fig. S2). The characteristics of the persons tested are shown in <a href="#t1">Table 1</a>, and vaccination status according to test result is shown in <a href="#t2">Table 2</a>. The distribution according to sex, geographic region, and race or ethnic group was similar to that in the full national Covid-19 case data, although there was a higher proportion of young adults (Table S1). Infection with the omicron variant 14 or more days after a booster occurred a median of 39 days (range, 14 to 118) after the booster.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t1.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/9c22b731-3ec9-4757-8186-a8b71a2d7a38/assets/images/large/nejmoa2119451_t1.jpg" height="3438" width="1480" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristic</th><th class="txxx-borders">Overall<br>(N=2,663,549)</th><th class="txxx-borders">Test-Negative Status<br>(N=1,572,621)</th><th class="txxx-borders">Delta Variant<br>(N=204,154)</th><th class="txxr-borders">Omicron Variant<br>(N=886,774)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row" data-xml-valign="bottom"><td class="xxlx-borders shading" data-xml-align="left">Percent of all participants</td><td class="xxxx-borders shading">100</td><td class="xxxx-borders shading">59.0</td><td class="xxxx-borders shading">7.7</td><td class="xxxr-borders shading">33.3</td></tr><tr data-type="row"><td class="xxlx-borders">Sex — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Female</td><td class="xxxx-borders shading">1,555,857 (58.4)</td><td class="xxxx-borders shading">955,508 (60.8)</td><td class="xxxx-borders shading">111,080 (54.4)</td><td class="xxxr-borders shading">489,269 (55.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Male</td><td class="xxxx-borders">1,102,797 (41.4)</td><td class="xxxx-borders">614,068 (39.0)</td><td class="xxxx-borders">92,764 (45.4)</td><td class="xxxr-borders">395,965 (44.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Missing data</td><td class="xxxx-borders shading">4,895 (0.2)</td><td class="xxxx-borders shading">3,045 (0.2)</td><td class="xxxx-borders shading">310 (0.2)</td><td class="xxxr-borders shading">1,540 (0.2)</td></tr><tr data-type="row"><td class="xxlx-borders">Age — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">18 or 19 yr</td><td class="xxxx-borders shading">86,559 (3.2)</td><td class="xxxx-borders shading">46,445 (3.0)</td><td class="xxxx-borders shading">4,055 (2.0)</td><td class="xxxr-borders shading">36,059 (4.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">20–24 yr</td><td class="xxxx-borders">279,465 (10.5)</td><td class="xxxx-borders">151,700 (9.6)</td><td class="xxxx-borders">14,071 (6.9)</td><td class="xxxr-borders">113,694 (12.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">25–29 yr</td><td class="xxxx-borders shading">336,504 (12.6)</td><td class="xxxx-borders shading">192,568 (12.2)</td><td class="xxxx-borders shading">20,227 (9.9)</td><td class="xxxr-borders shading">123,709 (14.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">30–34 yr</td><td class="xxxx-borders">355,731 (13.4)</td><td class="xxxx-borders">212,628 (13.5)</td><td class="xxxx-borders">26,484 (13.0)</td><td class="xxxr-borders">116,619 (13.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">35–39 yr</td><td class="xxxx-borders shading">327,751 (12.3)</td><td class="xxxx-borders shading">197,453 (12.6)</td><td class="xxxx-borders shading">30,097 (14.7)</td><td class="xxxr-borders shading">100,201 (11.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">40–44 yr</td><td class="xxxx-borders">283,074 (10.6)</td><td class="xxxx-borders">164,907 (10.5)</td><td class="xxxx-borders">31,936 (15.6)</td><td class="xxxr-borders">86,231 (9.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">45–49 yr</td><td class="xxxx-borders shading">244,583 (9.2)</td><td class="xxxx-borders shading">140,024 (8.9)</td><td class="xxxx-borders shading">26,862 (13.2)</td><td class="xxxr-borders shading">77,697 (8.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">50–54 yr</td><td class="xxxx-borders">231,704 (8.7)</td><td class="xxxx-borders">136,899 (8.7)</td><td class="xxxx-borders">20,326 (10.0)</td><td class="xxxr-borders">74,479 (8.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">55–59 yr</td><td class="xxxx-borders shading">193,831 (7.3)</td><td class="xxxx-borders shading">117,764 (7.5)</td><td class="xxxx-borders shading">14,943 (7.3)</td><td class="xxxr-borders shading">61,124 (6.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">60–64 yr</td><td class="xxxx-borders">131,656 (4.9)</td><td class="xxxx-borders">84,101 (5.3)</td><td class="xxxx-borders">8,187 (4.0)</td><td class="xxxr-borders">39,368 (4.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">65–69 yr</td><td class="xxxx-borders shading">80,267 (3.0)</td><td class="xxxx-borders shading">53,952 (3.4)</td><td class="xxxx-borders shading">3,251 (1.6)</td><td class="xxxr-borders shading">23,064 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">70–74 yr</td><td class="xxxx-borders">55,598 (2.1)</td><td class="xxxx-borders">36,893 (2.3)</td><td class="xxxx-borders">1,846 (0.9)</td><td class="xxxr-borders">16,859 (1.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">75–79 yr</td><td class="xxxx-borders shading">30,615 (1.1)</td><td class="xxxx-borders shading">19,748 (1.3)</td><td class="xxxx-borders shading">976 (0.5)</td><td class="xxxr-borders shading">9,891 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">80–84 yr</td><td class="xxxx-borders">15,333 (0.6)</td><td class="xxxx-borders">10,058 (0.6)</td><td class="xxxx-borders">488 (0.2)</td><td class="xxxr-borders">4,787 (0.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">85–89 yr</td><td class="xxxx-borders shading">7,452 (0.3)</td><td class="xxxx-borders shading">5,069 (0.3)</td><td class="xxxx-borders shading">279 (0.1)</td><td class="xxxr-borders shading">2,104 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">≥90 yr</td><td class="xxxx-borders">3,426 (0.1)</td><td class="xxxx-borders">2,412 (0.2)</td><td class="xxxx-borders">126 (0.1)</td><td class="xxxr-borders">888 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders shading">Race or ethnic group — no. (%)<a href="#t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">African</td><td class="xxxx-borders">39,865 (1.5)</td><td class="xxxx-borders">19,439 (1.2)</td><td class="xxxx-borders">1,851 (0.9)</td><td class="xxxr-borders">18,575 (2.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Caribbean</td><td class="xxxx-borders shading">23,070 (0.9)</td><td class="xxxx-borders shading">10,052 (0.6)</td><td class="xxxx-borders shading">1,527 (0.7)</td><td class="xxxr-borders shading">11,491 (1.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Another Black background</td><td class="xxxx-borders">3,955 (0.1)</td><td class="xxxx-borders">1,938 (0.1)</td><td class="xxxx-borders">241 (0.1)</td><td class="xxxr-borders">1,776 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Arab</td><td class="xxxx-borders shading">8,743 (0.3)</td><td class="xxxx-borders shading">5,271 (0.3)</td><td class="xxxx-borders shading">660 (0.3)</td><td class="xxxr-borders shading">2,812 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Bangladeshi</td><td class="xxxx-borders">18,372 (0.7)</td><td class="xxxx-borders">10,836 (0.7)</td><td class="xxxx-borders">1,231 (0.6)</td><td class="xxxr-borders">6,305 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Chinese</td><td class="xxxx-borders shading">17,803 (0.7)</td><td class="xxxx-borders shading">10,967 (0.7)</td><td class="xxxx-borders shading">1,142 (0.6)</td><td class="xxxr-borders shading">5,694 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Indian</td><td class="xxxx-borders">88,486 (3.3)</td><td class="xxxx-borders">57,385 (3.6)</td><td class="xxxx-borders">4,574 (2.2)</td><td class="xxxr-borders">26,527 (3.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Pakistani</td><td class="xxxx-borders shading">46,291 (1.7)</td><td class="xxxx-borders shading">27,417 (1.7)</td><td class="xxxx-borders shading">3,004 (1.5)</td><td class="xxxr-borders shading">15,870 (1.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Another Asian background</td><td class="xxxx-borders">34,867 (1.3)</td><td class="xxxx-borders">19,979 (1.3)</td><td class="xxxx-borders">2,082 (1.0)</td><td class="xxxr-borders">12,806 (1.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Mixed or multiple ethnic groups</td><td class="xxxx-borders shading">52,395 (2.0)</td><td class="xxxx-borders shading">29,291 (1.9)</td><td class="xxxx-borders shading">3,358 (1.6)</td><td class="xxxr-borders shading">19,746 (2.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">White</td><td class="xxxx-borders">2,215,756 (83.2)</td><td class="xxxx-borders">1,312,372 (83.5)</td><td class="xxxx-borders">176,390 (86.4)</td><td class="xxxr-borders">726,994 (82.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Another ethnic background</td><td class="xxxx-borders shading">18,302 (0.7)</td><td class="xxxx-borders shading">10,715 (0.7)</td><td class="xxxx-borders shading">1,180 (0.6)</td><td class="xxxr-borders shading">6,407 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Prefer not to say</td><td class="xxxx-borders">95,644 (3.6)</td><td class="xxxx-borders">56,959 (3.6)</td><td class="xxxx-borders">6,914 (3.4)</td><td class="xxxr-borders">31,771 (3.6)</td></tr><tr data-type="row"><td class="xxlx-borders shading">NHS region — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">East of England</td><td class="xxxx-borders">287,326 (10.8)</td><td class="xxxx-borders">191,259 (12.2)</td><td class="xxxx-borders">22,695 (11.1)</td><td class="xxxr-borders">73,372 (8.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">London</td><td class="xxxx-borders shading">411,785 (15.5)</td><td class="xxxx-borders shading">237,614 (15.1)</td><td class="xxxx-borders shading">24,571 (12.0)</td><td class="xxxr-borders shading">149,600 (16.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Midlands</td><td class="xxxx-borders">455,325 (17.1)</td><td class="xxxx-borders">280,909 (17.9)</td><td class="xxxx-borders">35,860 (17.6)</td><td class="xxxr-borders">138,556 (15.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">North East</td><td class="xxxx-borders shading">414,437 (15.6)</td><td class="xxxx-borders shading">232,576 (14.8)</td><td class="xxxx-borders shading">32,467 (15.9)</td><td class="xxxr-borders shading">149,394 (16.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">North West</td><td class="xxxx-borders">444,930 (16.7)</td><td class="xxxx-borders">207,429 (13.2)</td><td class="xxxx-borders">33,404 (16.4)</td><td class="xxxr-borders">204,097 (23.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">South East</td><td class="xxxx-borders shading">406,968 (15.3)</td><td class="xxxx-borders shading">257,588 (16.4)</td><td class="xxxx-borders shading">33,720 (16.5)</td><td class="xxxr-borders shading">115,660 (13.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">South West</td><td class="xxxx-borders">242,772 (9.1)</td><td class="xxxx-borders">165,240 (10.5)</td><td class="xxxx-borders">21,437 (10.5)</td><td class="xxxr-borders">56,095 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Missing</td><td class="xxxx-borders shading">6 (&lt;0.1)</td><td class="xxxx-borders shading">6 (&lt;0.1)</td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">0</td></tr><tr data-type="row"><td class="xxlx-borders">Index of multiple deprivation — no. (%)<a href="#t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">1</td><td class="xxxx-borders shading">482,884 (18.1)</td><td class="xxxx-borders shading">261,116 (16.6)</td><td class="xxxx-borders shading">37,433 (18.3)</td><td class="xxxr-borders shading">184,335 (20.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">2</td><td class="xxxx-borders">529,594 (19.9)</td><td class="xxxx-borders">305,748 (19.4)</td><td class="xxxx-borders">39,456 (19.3)</td><td class="xxxr-borders">184,390 (20.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">3</td><td class="xxxx-borders shading">540,303 (20.3)</td><td class="xxxx-borders shading">325,218 (20.7)</td><td class="xxxx-borders shading">41,308 (20.2)</td><td class="xxxr-borders shading">173,777 (19.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">4</td><td class="xxxx-borders">551,055 (20.7)</td><td class="xxxx-borders">333,456 (21.2)</td><td class="xxxx-borders">42,602 (20.9)</td><td class="xxxr-borders">174,997 (19.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">5</td><td class="xxxx-borders shading">550,254 (20.7)</td><td class="xxxx-borders shading">341,620 (21.7)</td><td class="xxxx-borders shading">42,756 (20.9)</td><td class="xxxr-borders shading">165,878 (18.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Missing data</td><td class="xxxx-borders">9,459 (0.4)</td><td class="xxxx-borders">5,463 (0.3)</td><td class="xxxx-borders">599 (0.3)</td><td class="xxxr-borders">3,397 (0.4)</td></tr><tr data-type="row"><td class="xxlx-borders shading">Previously tested positive — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">No</td><td class="xxxx-borders">2,301,572 (86.4)</td><td class="xxxx-borders">1,312,548 (83.5)</td><td class="xxxx-borders">200,400 (98.2)</td><td class="xxxr-borders">788,624 (88.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Yes</td><td class="xxxx-borders shading">361,977 (13.6)</td><td class="xxxx-borders shading">260,073 (16.5)</td><td class="xxxx-borders shading">3,754 (1.8)</td><td class="xxxr-borders shading">98,150 (11.1)</td></tr><tr data-type="row"><td class="xxlx-borders">Vaccine priority group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Health and social care worker</td><td class="xxxx-borders shading">164,113 (6.2)</td><td class="xxxx-borders shading">113,183 (7.2)</td><td class="xxxx-borders shading">5,657 (2.8)</td><td class="xxxr-borders shading">45,273 (5.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Clinically extremely vulnerable</td><td class="xxxx-borders">142,002 (5.3)</td><td class="xxxx-borders">93,236 (5.9)</td><td class="xxxx-borders">7,443 (3.6)</td><td class="xxxr-borders">41,323 (4.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">At risk</td><td class="xxxx-borders shading">482,075 (18.1)</td><td class="xxxx-borders shading">307,240 (19.5)</td><td class="xxxx-borders shading">32,490 (15.9)</td><td class="xxxr-borders shading">142,345 (16.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">Severely immunosuppressed</td><td class="xbxx-borders">22,391 (0.8)</td><td class="xbxx-borders">13,985 (0.9)</td><td class="xbxx-borders">1,191 (0.6)</td><td class="xbxr-borders">7,215 (0.8)</td></tr></tbody></table></div><figcaption><div class="caption">Characteristics of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">B.1.617.2 is the delta variant, and B.1.1.529 the omicron variant, of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Percentages may not total 100 because of rounding.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t1fn2" role="paragraph">Race or ethnic group was determined from data in the National Immunisation Management System register.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t1fn3" role="paragraph">The index of multiple deprivation is a national indicator of level of deprivation on the basis of small geographic areas of residence; the index ranges from 1 (least deprived) to 5 (most deprived).</div></div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 2</div><nav><a href="#t2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t2" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t2.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/04ef3106-41f7-4b58-8af9-62f2ac0f6cc9/assets/images/large/nejmoa2119451_t2.jpg" height="3438" width="1219" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Vaccination Status, Dose, and Interval after Vaccination</th><th class="txxx-borders">Overall<br>(N=2,663,549)</th><th class="txxx-borders">Test-Negative Status<br>(N=1,572,621)</th><th class="txxx-borders">Delta Variant<br>(N=204,154)</th><th class="txxr-borders">Omicron Variant<br>(N=886,774)</th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders">&nbsp;</td><th class="xxxr-borders" colspan="4"><span>number (percent)</span></th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging04 shading" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders shading">244,716 (9.2)</td><td class="xxxx-borders shading">107,238 (6.8)</td><td class="xxxx-borders shading">36,369 (17.8)</td><td class="xxxr-borders shading">101,109 (11.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0–3 wk</td><td class="xxxx-borders">64 (&lt;0.1)</td><td class="xxxx-borders">33 (&lt;0.1)</td><td class="xxxx-borders">8 (&lt;0.1)</td><td class="xxxr-borders">23 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥4 wk</td><td class="xxxx-borders shading">16,150 (0.6)</td><td class="xxxx-borders shading">8,470 (0.5)</td><td class="xxxx-borders shading">2,133 (1.0)</td><td class="xxxr-borders shading">5,547 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders shading">406 (&lt;0.1)</td><td class="xxxx-borders shading">224 (&lt;0.1)</td><td class="xxxx-borders shading">34 (&lt;0.1)</td><td class="xxxr-borders shading">148 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">740 (&lt;0.1)</td><td class="xxxx-borders">476 (&lt;0.1)</td><td class="xxxx-borders">28 (&lt;0.1)</td><td class="xxxr-borders">236 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">1,484 (0.1)</td><td class="xxxx-borders shading">894 (0.1)</td><td class="xxxx-borders shading">85 (&lt;0.1)</td><td class="xxxr-borders shading">505 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">2,700 (0.1)</td><td class="xxxx-borders">1,659 (0.1)</td><td class="xxxx-borders">274 (0.1)</td><td class="xxxr-borders">767 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">17,775 (0.7)</td><td class="xxxx-borders shading">10,788 (0.7)</td><td class="xxxx-borders shading">4,013 (2.0)</td><td class="xxxr-borders shading">2,974 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">120,979 (4.5)</td><td class="xxxx-borders">68,757 (4.4)</td><td class="xxxx-borders">29,100 (14.3)</td><td class="xxxr-borders">23,122 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">292,794 (11.0)</td><td class="xxxx-borders shading">147,721 (9.4)</td><td class="xxxx-borders shading">46,103 (22.6)</td><td class="xxxr-borders shading">98,970 (11.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders shading">102,033 (3.8)</td><td class="xxxx-borders shading">54,613 (3.5)</td><td class="xxxx-borders shading">13,404 (6.6)</td><td class="xxxr-borders shading">34,016 (3.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">BNT162b2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">60,212 (2.3)</td><td class="xxxx-borders shading">40,203 (2.6)</td><td class="xxxx-borders shading">2,088 (1.0)</td><td class="xxxr-borders shading">17,921 (2.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">165,248 (6.2)</td><td class="xxxx-borders">114,050 (7.3)</td><td class="xxxx-borders">2,029 (1.0)</td><td class="xxxr-borders">49,169 (5.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">157,008 (5.9)</td><td class="xxxx-borders shading">98,853 (6.3)</td><td class="xxxx-borders shading">2,291 (1.1)</td><td class="xxxr-borders shading">55,864 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">34,081 (1.3)</td><td class="xxxx-borders">18,168 (1.2)</td><td class="xxxx-borders">343 (0.2)</td><td class="xxxr-borders">15,570 (1.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">31,958 (1.2)</td><td class="xxxx-borders">22,722 (1.4)</td><td class="xxxx-borders">845 (0.4)</td><td class="xxxr-borders">8,391 (0.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">76,935 (2.9)</td><td class="xxxx-borders shading">53,353 (3.4)</td><td class="xxxx-borders shading">417 (0.2)</td><td class="xxxr-borders shading">23,165 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">22,745 (0.9)</td><td class="xxxx-borders">13,917 (0.9)</td><td class="xxxx-borders">92 (&lt;0.1)</td><td class="xxxr-borders">8,736 (1.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">80 (&lt;0.1)</td><td class="xxxx-borders shading">38 (&lt;0.1)</td><td class="xxxx-borders shading">1 (&lt;0.1)</td><td class="xxxr-borders shading">41 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">158 (&lt;0.1)</td><td class="xxxx-borders shading">107 (&lt;0.1)</td><td class="xxxx-borders shading">10 (&lt;0.1)</td><td class="xxxr-borders shading">41 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">444 (&lt;0.1)</td><td class="xxxx-borders">294 (&lt;0.1)</td><td class="xxxx-borders">19 (&lt;0.1)</td><td class="xxxr-borders">131 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">440 (&lt;0.1)</td><td class="xxxx-borders shading">264 (&lt;0.1)</td><td class="xxxx-borders shading">12 (&lt;0.1)</td><td class="xxxr-borders shading">164 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">84 (&lt;0.1)</td><td class="xxxx-borders">48 (&lt;0.1)</td><td class="xxxx-borders">0</td><td class="xxxr-borders">36 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">12,530 (0.5)</td><td class="xxxx-borders shading">7,038 (0.4)</td><td class="xxxx-borders shading">944 (0.5)</td><td class="xxxr-borders shading">4,548 (0.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">54,183 (2.0)</td><td class="xxxx-borders">29,759 (1.9)</td><td class="xxxx-borders">5,381 (2.6)</td><td class="xxxr-borders">19,043 (2.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders">9,001 (0.3)</td><td class="xxxx-borders">5,900 (0.4)</td><td class="xxxx-borders">466 (0.2)</td><td class="xxxr-borders">2,635 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">13,125 (0.5)</td><td class="xxxx-borders shading">9,516 (0.6)</td><td class="xxxx-borders shading">240 (0.1)</td><td class="xxxr-borders shading">3,369 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">29,912 (1.1)</td><td class="xxxx-borders">20,163 (1.3)</td><td class="xxxx-borders">981 (0.5)</td><td class="xxxr-borders">8,768 (1.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">91,754 (3.4)</td><td class="xxxx-borders shading">61,014 (3.9)</td><td class="xxxx-borders shading">5,562 (2.7)</td><td class="xxxr-borders shading">25,178 (2.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">243,470 (9.1)</td><td class="xxxx-borders">144,172 (9.2)</td><td class="xxxx-borders">17,077 (8.4)</td><td class="xxxr-borders">82,221 (9.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">138,085 (5.2)</td><td class="xxxx-borders shading">72,018 (4.6)</td><td class="xxxx-borders shading">10,348 (5.1)</td><td class="xxxr-borders shading">55,719 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">94,139 (3.5)</td><td class="xxxx-borders">51,625 (3.3)</td><td class="xxxx-borders">8,531 (4.2)</td><td class="xxxr-borders">33,983 (3.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders">80,592 (3.0)</td><td class="xxxx-borders">44,166 (2.8)</td><td class="xxxx-borders">3,212 (1.6)</td><td class="xxxr-borders">33,214 (3.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">44,705 (1.7)</td><td class="xxxx-borders">29,459 (1.9)</td><td class="xxxx-borders">631 (0.3)</td><td class="xxxr-borders">14,615 (1.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">87,980 (3.3)</td><td class="xxxx-borders shading">64,874 (4.1)</td><td class="xxxx-borders shading">1,220 (0.6)</td><td class="xxxr-borders shading">21,886 (2.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">156,929 (5.9)</td><td class="xxxx-borders">110,306 (7.0)</td><td class="xxxx-borders">3,769 (1.8)</td><td class="xxxr-borders">42,854 (4.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">104,325 (3.9)</td><td class="xxxx-borders shading">61,534 (3.9)</td><td class="xxxx-borders shading">1,222 (0.6)</td><td class="xxxr-borders shading">41,569 (4.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">18,221 (0.7)</td><td class="xxxx-borders shading">12,718 (0.8)</td><td class="xxxx-borders shading">195 (0.1)</td><td class="xxxr-borders shading">5,308 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">27,480 (1.0)</td><td class="xxxx-borders">20,045 (1.3)</td><td class="xxxx-borders">147 (0.1)</td><td class="xxxr-borders">7,288 (0.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">8,158 (0.3)</td><td class="xxxx-borders shading">5,311 (0.3)</td><td class="xxxx-borders shading">40 (&lt;0.1)</td><td class="xxxr-borders shading">2,807 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">87 (&lt;0.1)</td><td class="xxxx-borders">53 (&lt;0.1)</td><td class="xxxx-borders">1 (&lt;0.1)</td><td class="xxxr-borders">33 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">2,544 (0.1)</td><td class="xxxx-borders shading">1,429 (0.1)</td><td class="xxxx-borders shading">134 (0.1)</td><td class="xxxr-borders shading">981 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">5,656 (0.2)</td><td class="xxxx-borders">3,122 (0.2)</td><td class="xxxx-borders">448 (0.2)</td><td class="xxxr-borders">2,086 (0.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders">682 (&lt;0.1)</td><td class="xxxx-borders">467 (&lt;0.1)</td><td class="xxxx-borders">35 (&lt;0.1)</td><td class="xxxr-borders">180 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">1,104 (&lt;0.1)</td><td class="xxxx-borders shading">855 (0.1)</td><td class="xxxx-borders shading">13 (&lt;0.1)</td><td class="xxxr-borders shading">236 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">3,150 (0.1)</td><td class="xxxx-borders">2,286 (0.1)</td><td class="xxxx-borders">73 (&lt;0.1)</td><td class="xxxr-borders">791 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">14,324 (0.5)</td><td class="xxxx-borders shading">9,822 (0.6)</td><td class="xxxx-borders shading">674 (0.3)</td><td class="xxxr-borders shading">3,828 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">32,913 (1.2)</td><td class="xxxx-borders">20,017 (1.3)</td><td class="xxxx-borders">1,627 (0.8)</td><td class="xxxr-borders">11,269 (1.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">16,291 (0.6)</td><td class="xxxx-borders shading">8,961 (0.6)</td><td class="xxxx-borders shading">1,224 (0.6)</td><td class="xxxr-borders shading">6,106 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">1,221 (&lt;0.1)</td><td class="xxxx-borders">474 (&lt;0.1)</td><td class="xxxx-borders">16 (&lt;0.1)</td><td class="xxxr-borders">731 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders">8,787 (0.3)</td><td class="xxxx-borders">4,745 (0.3)</td><td class="xxxx-borders">203 (0.1)</td><td class="xxxr-borders">3,839 (0.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">3,439 (0.1)</td><td class="xxxx-borders">2,031 (0.1)</td><td class="xxxx-borders">15 (&lt;0.1)</td><td class="xxxr-borders">1,393 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">3,410 (0.1)</td><td class="xxxx-borders shading">2,063 (0.1)</td><td class="xxxx-borders shading">8 (&lt;0.1)</td><td class="xxxr-borders shading">1,339 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">36 (&lt;0.1)</td><td class="xxxx-borders">20 (&lt;0.1)</td><td class="xxxx-borders">0</td><td class="xxxr-borders">16 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">3 (&lt;0.1)</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">3 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">3,001 (0.1)</td><td class="xxxx-borders shading">1,851 (0.1)</td><td class="xxxx-borders shading">14 (&lt;0.1)</td><td class="xxxr-borders shading">1,136 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">3,067 (0.1)</td><td class="xxxx-borders">1,913 (0.1)</td><td class="xxxx-borders">5 (&lt;0.1)</td><td class="xxxr-borders">1,149 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xbxx-borders shading">11 (&lt;0.1)</td><td class="xbxx-borders shading">4 (&lt;0.1)</td><td class="xbxx-borders shading">0</td><td class="xbxr-borders shading">7 (&lt;0.1)</td></tr></tbody></table></div><figcaption>Vaccination Status of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.</figcaption></figure></div></section><section id="sec-2-2"><h3>Vaccine Effectiveness, Delta Variant</h3><div role="paragraph">Vaccine effectiveness against symptomatic disease in persons who received a primary course of the ChAdOx1 nCoV-19, BNT162b2, or mRNA-1273 vaccine according to period after primary immunization with second doses and after a third dose with BNT162b2 or mRNA-1273 is shown in <a href="#f1">Figure 1</a> and <a href="#t3">Table 3</a> and S2. With the delta variant, vaccine effectiveness after two doses of ChAdOx1 nCoV-19 primary course started at 82.8% (95% confidence interval [CI], 74.5 to 88.4) after 2 to 4 weeks but waned to 43.5% (95% CI, 42.4 to 44.5) after 25 or more weeks. With the messenger RNA (mRNA) vaccines, effectiveness after two doses was higher in all periods, but there was also evidence of waning. After a booster with an mRNA vaccine, vaccine effectiveness reached more than 95% with any of the primary courses and remained high up to the longest follow-up points (maximum, ≥10 weeks).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119451_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119451_f1.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/d2f1d981-336f-4a21-bbe3-ef0a852a2d2a/assets/images/large/nejmoa2119451_f1.jpg" height="3438" width="2456" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants, According to the Period after the Second and Booster Doses.</div><div class="notes"><div role="doc-footnote">B.1.617.2 is the delta variant, and B.1.1.529 the omicron variant, of the severe acute respiratory syndrome coronavirus 2. 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 3</div><nav><a href="#t3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t3" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t3" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t3.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/6455aa8a-43e5-4270-a78a-5615cfed371f/assets/images/large/nejmoa2119451_t3.jpg" height="3438" width="1266" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Vaccination Status, Dose, and Interval after Vaccination</th><th class="txxx-borders">Test-Negative Status</th><th class="txxx-borders" colspan="2"><span>Delta Variant</span></th><th class="txxr-borders" colspan="2"><span>Omicron Variant</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Controls</th><th class="xxxx-borders">Case Participants</th><th class="xxxx-borders">Vaccine Effectiveness (95% CI)<a href="#t3fn2" role="doc-noteref">†</a></th><th class="xxxx-borders">Case Participants</th><th class="xxxr-borders">Vaccine Effectiveness (95% CI)<a href="#t3fn2" role="doc-noteref">†</a></th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">no.</th><th class="xxxx-borders">no.</th><th class="xxxx-borders">%</th><th class="xxxx-borders">no.</th><th class="xxxr-borders">%</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders shading" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders shading">107,238</td><td class="xxxx-borders shading">36,369</td><td class="xxxx-borders shading">Reference</td><td class="xxxx-borders shading">101,109</td><td class="xxxr-borders shading">Reference</td></tr><tr data-type="row"><td class="xxlx-borders">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0–3 wk</td><td class="xxxx-borders">33</td><td class="xxxx-borders">8</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">23</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥4 wk</td><td class="xxxx-borders shading">8,470</td><td class="xxxx-borders shading">2,133</td><td class="xxxx-borders shading">42.9 (39.8 to 45.9)</td><td class="xxxx-borders shading">5,547</td><td class="xxxr-borders shading">17.7 (14.3 to 21.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">476</td><td class="xxxx-borders shading">28</td><td class="xxxx-borders shading">82.8 (74.5 to 88.4)</td><td class="xxxx-borders shading">236</td><td class="xxxr-borders shading">48.9 (39.2 to 57.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">894</td><td class="xxxx-borders">85</td><td class="xxxx-borders">76.5 (70.3 to 81.5)</td><td class="xxxx-borders">505</td><td class="xxxr-borders">33.7 (25.0 to 41.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">1,659</td><td class="xxxx-borders shading">274</td><td class="xxxx-borders shading">69.2 (64.7 to 73.1)</td><td class="xxxx-borders shading">767</td><td class="xxxr-borders shading">28.6 (20.9 to 35.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">10,788</td><td class="xxxx-borders">4,013</td><td class="xxxx-borders">53.6 (51.6 to 55.5)</td><td class="xxxx-borders">2,974</td><td class="xxxr-borders">17.8 (13.4 to 21.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">68,757</td><td class="xxxx-borders shading">29,100</td><td class="xxxx-borders shading">47.4 (46.2 to 48.5)</td><td class="xxxx-borders shading">23,122</td><td class="xxxr-borders shading">4.0 (1.9 to 6.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">147,721</td><td class="xxxx-borders">46,103</td><td class="xxxx-borders">43.5 (42.4 to 44.5)</td><td class="xxxx-borders">98,970</td><td class="xxxr-borders">−2.7 (−4.2 to −1.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">BNT162b2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">40,203</td><td class="xxxx-borders shading">2,088</td><td class="xxxx-borders shading">88.7 (88.1 to 89.2)</td><td class="xxxx-borders shading">17,921</td><td class="xxxr-borders shading">58.8 (57.8 to 59.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">114,050</td><td class="xxxx-borders">2,029</td><td class="xxxx-borders">95.4 (95.1 to 95.6)</td><td class="xxxx-borders">49,169</td><td class="xxxr-borders">62.4 (61.8 to 63.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">98,853</td><td class="xxxx-borders shading">2,291</td><td class="xxxx-borders shading">92.6 (92.2 to 92.9)</td><td class="xxxx-borders shading">55,864</td><td class="xxxr-borders shading">52.9 (52.1 to 53.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">18,168</td><td class="xxxx-borders">343</td><td class="xxxx-borders">88.1 (86.7 to 89.3)</td><td class="xxxx-borders">15,570</td><td class="xxxr-borders">39.6 (38.0 to 41.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">22,722</td><td class="xxxx-borders">845</td><td class="xxxx-borders">91.5 (90.9 to 92.1)</td><td class="xxxx-borders">8,391</td><td class="xxxr-borders">68.0 (67.0 to 68.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">53,353</td><td class="xxxx-borders shading">417</td><td class="xxxx-borders shading">97.0 (96.7 to 97.3)</td><td class="xxxx-borders shading">23,165</td><td class="xxxr-borders shading">70.1 (69.5 to 70.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">13,917</td><td class="xxxx-borders">92</td><td class="xxxx-borders">94.9 (93.8 to 95.9)</td><td class="xxxx-borders">8,736</td><td class="xxxr-borders">60.9 (59.7 to 62.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">38</td><td class="xxxx-borders shading">1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">41</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">107</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">77.1 (55.1 to 88.3)</td><td class="xxxx-borders shading">41</td><td class="xxxr-borders shading">57.7 (37.6 to 71.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">294</td><td class="xxxx-borders">19</td><td class="xxxx-borders">82.3 (71.3 to 89.0)</td><td class="xxxx-borders">131</td><td class="xxxr-borders">55.6 (44.4 to 64.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">264</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">83.3 (69.7 to 90.8)</td><td class="xxxx-borders shading">164</td><td class="xxxr-borders shading">46.7 (34.3 to 56.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">48</td><td class="xxxx-borders">0</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">36</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">7,038</td><td class="xxxx-borders shading">5381</td><td class="xxxx-borders shading">45.2 (43.3 to 47.1)</td><td class="xxxx-borders shading">4,548</td><td class="xxxr-borders shading">42.8 (40.3 to 45.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">29,759</td><td class="xxxx-borders">466</td><td class="xxxx-borders">72.3 (69.4 to 74.9)</td><td class="xxxx-borders">19,043</td><td class="xxxr-borders">31.5 (29.9 to 33.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">9,516</td><td class="xxxx-borders">240</td><td class="xxxx-borders">90.9 (89.6 to 92.0)</td><td class="xxxx-borders">3,369</td><td class="xxxr-borders">65.5 (63.9 to 67.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">20,163</td><td class="xxxx-borders shading">981</td><td class="xxxx-borders shading">85.5 (84.5 to 86.5)</td><td class="xxxx-borders shading">8,768</td><td class="xxxr-borders shading">48.7 (47.1 to 50.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">61,014</td><td class="xxxx-borders">5,562</td><td class="xxxx-borders">78.7 (78.0 to 79.4)</td><td class="xxxx-borders">25,178</td><td class="xxxr-borders">30.1 (28.7 to 31.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">144,172</td><td class="xxxx-borders shading">17,077</td><td class="xxxx-borders shading">74.4 (73.8 to 74.9)</td><td class="xxxx-borders shading">82,221</td><td class="xxxr-borders shading">15.4 (14.2 to 16.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">72,018</td><td class="xxxx-borders">10,348</td><td class="xxxx-borders">67.4 (66.5 to 68.2)</td><td class="xxxx-borders">55,719</td><td class="xxxr-borders">11.5 (10.1 to 12.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">51,625</td><td class="xxxx-borders shading">8,531</td><td class="xxxx-borders shading">62.7 (61.6 to 63.7)</td><td class="xxxx-borders shading">33,983</td><td class="xxxr-borders shading">8.8 (7.0 to 10.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">29,459</td><td class="xxxx-borders">631</td><td class="xxxx-borders">92.3 (91.6 to 92.9)</td><td class="xxxx-borders">14,615</td><td class="xxxr-borders">66.9 (66.1 to 67.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">64,874</td><td class="xxxx-borders shading">1,220</td><td class="xxxx-borders shading">95.1 (94.8 to 95.4)</td><td class="xxxx-borders shading">21,886</td><td class="xxxr-borders shading">67.2 (66.5 to 67.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">110,306</td><td class="xxxx-borders">3,769</td><td class="xxxx-borders">91.8 (91.4 to 92.1)</td><td class="xxxx-borders">42,854</td><td class="xxxr-borders">55.0 (54.2 to 55.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">61,534</td><td class="xxxx-borders shading">1,222</td><td class="xxxx-borders shading">89.9 (89.2 to 90.5)</td><td class="xxxx-borders shading">41,569</td><td class="xxxr-borders shading">45.7 (44.7 to 46.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">12,718</td><td class="xxxx-borders shading">195</td><td class="xxxx-borders shading">93.7 (92.7 to 94.6)</td><td class="xxxx-borders shading">5,308</td><td class="xxxr-borders shading">74.0 (73.1 to 74.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">20,045</td><td class="xxxx-borders">147</td><td class="xxxx-borders">96.6 (96.0 to 97.1)</td><td class="xxxx-borders">7,288</td><td class="xxxr-borders">73.9 (73.1 to 74.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">5,311</td><td class="xxxx-borders shading">40</td><td class="xxxx-borders shading">94.9 (93.0 to 96.2)</td><td class="xxxx-borders shading">2,807</td><td class="xxxr-borders shading">64.4 (62.6 to 66.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">53</td><td class="xxxx-borders">1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">33</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">1,429</td><td class="xxxx-borders shading">134</td><td class="xxxx-borders shading">60.1 (51.8 to 66.9)</td><td class="xxxx-borders shading">981</td><td class="xxxr-borders shading">47.9 (43.1 to 52.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">3,122</td><td class="xxxx-borders">448</td><td class="xxxx-borders">57.4 (52.6 to 61.8)</td><td class="xxxx-borders">2,086</td><td class="xxxr-borders">31.9 (27.3 to 36.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">855</td><td class="xxxx-borders">13</td><td class="xxxx-borders">94.5 (90.5 to 96.9)</td><td class="xxxx-borders">236</td><td class="xxxr-borders">75.1 (70.8 to 78.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">2,286</td><td class="xxxx-borders shading">73</td><td class="xxxx-borders shading">91.8 (89.6 to 93.6)</td><td class="xxxx-borders shading">791</td><td class="xxxr-borders shading">52.8 (48.2 to 57.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">9,822</td><td class="xxxx-borders">674</td><td class="xxxx-borders">84.1 (82.7 to 85.3)</td><td class="xxxx-borders">3,828</td><td class="xxxr-borders">35.6 (32.7 to 38.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">20,017</td><td class="xxxx-borders shading">1,627</td><td class="xxxx-borders shading">82.8 (81.8 to 83.7)</td><td class="xxxx-borders shading">11,269</td><td class="xxxr-borders shading">25.3 (23.2 to 27.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">8,961</td><td class="xxxx-borders">1,224</td><td class="xxxx-borders">76.2 (74.7 to 77.7)</td><td class="xxxx-borders">6,106</td><td class="xxxr-borders">15.0 (11.6 to 18.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">474</td><td class="xxxx-borders shading">16</td><td class="xxxx-borders shading">80.4 (67.3 to 88.2)</td><td class="xxxx-borders shading">731</td><td class="xxxr-borders shading">14.9 (3.9 to 24.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">2,031</td><td class="xxxx-borders">15</td><td class="xxxx-borders">95.5 (92.5 to 97.3)</td><td class="xxxx-borders">1,393</td><td class="xxxr-borders">64.3 (61.7 to 66.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">2,063</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">94.7 (89.3 to 97.3)</td><td class="xxxx-borders shading">1,339</td><td class="xxxr-borders shading">64.9 (62.3 to 67.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">20</td><td class="xxxx-borders">0</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">16</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">3</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">1,851</td><td class="xxxx-borders shading">14</td><td class="xxxx-borders shading">95.3 (92.1 to 97.2)</td><td class="xxxx-borders shading">1,136</td><td class="xxxr-borders shading">68.1 (65.6 to 70.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">1,913</td><td class="xxxx-borders">5</td><td class="xxxx-borders">96.4 (91.4 to 98.5)</td><td class="xxxx-borders">1,149</td><td class="xxxr-borders">66.3 (63.7 to 68.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xbxx-borders shading">4</td><td class="xbxx-borders shading">0</td><td class="xbxx-borders shading">&nbsp;</td><td class="xbxx-borders shading">7</td><td class="xbxr-borders shading">&nbsp;</td></tr></tbody></table></div><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants.<a href="#t3fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t3fn1" role="paragraph">CI denotes confidence interval.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t3fn2" role="paragraph">To ensure reasonable precision, estimates are given if there are at least 10 case participants or 2000 controls.</div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Vaccine Effectiveness, Omicron Variant</h3><div role="paragraph">Vaccine effectiveness was lower for the omicron variant than for the delta variant at all intervals after vaccination and for all combinations of primary courses and booster doses investigated. Among those who had received two ChAdOx1 nCoV-19 doses, almost no protective effect of vaccination against symptomatic disease caused by the omicron variant was noted from 20 to 24 weeks after the second dose. Among those who had received two BNT162b2 doses, vaccine effectiveness was 65.5% (95% CI, 63.9 to 67.0) 2 to 4 weeks after the second dose, dropping to 15.4% (95% CI, 14.2 to 16.6) after 15 to 19 weeks and dropping further to 8.8% (95% CI, 7.0 to 10.5) after 25 or more weeks. The vaccine effectiveness of two doses of mRNA-1273 vaccine had a similar reduction over time from 75.1% (95% CI, 70.8 to 78.7) after 2 to 4 weeks to 14.9% (95% CI, 3.9 to 24.7) after 25 or more weeks.</div><div role="paragraph">Among persons who received ChAdOx1 nCoV-19 as the primary course, from 2 to 4 weeks after a BNT162b2 booster dose, vaccine effectiveness increased to 62.4% (95% CI, 61.8 to 63.0) before waning to 39.6% (95% CI, 38.0 to 41.1) after 10 or more weeks. The mRNA-1273 booster vaccine increased effectiveness to 70.1% (95% CI, 69.5 to 70.7) after 2 to 4 weeks. This waned to 60.9% (95% CI, 59.7 to 62.1) after 5 to 9 weeks. Vaccine effectiveness was lowest among those who received a ChAdOx1 nCoV-19 primary course with a ChAdOx1 nCoV-19 booster vaccine. Waning efficacy was most notable against the omicron variant, for which the vaccine effectiveness was 46.7% (95% CI, 34.3 to 56.7) at 5 to 9 weeks.</div><div role="paragraph">Among persons who received BNT162b2 as the primary course, from 2 to 4 weeks after a BNT162b2 booster dose, vaccine effectiveness increased to 67.2% (95% CI, 66.5 to 67.8) before declining to 45.7% (95% CI, 44.7 to 46.7) after 10 or more weeks. The mRNA-1273 booster increased vaccine effectiveness to 73.9% (95% CI, 73.1 to 74.6) after 2 to 4 weeks before decreasing to 64.4% (95% CI, 62.6 to 66.1) after 5 to 9 weeks. After an mRNA-1273 primary course, vaccine effectiveness increased to 64.9% (95% CI, 62.3 to 67.3) at 2 to 4 weeks after a BNT162b2 booster and 66.3% (95% CI, 63.7 to 68.8) at 2 to 4 weeks after an mRNA-1273 booster.</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">Our findings indicate that vaccine effectiveness against symptomatic disease caused by the omicron variant is substantially lower than with the delta variant. After two doses, vaccine effectiveness waned rapidly, with very limited vaccine effects seen from 20 weeks after the second dose of any vaccine. Booster doses resulted in a substantial increase in protection against mild infection; however, waning of protection against symptomatic disease was also seen after booster doses. We are unable to determine protection against severe forms of disease using the test-negative case–control method here owing to the small number of omicron cases resulting in hospitalization so far in our data set and the natural lag between infection and more severe outcomes. Previous experience with the delta variant in the United Kingdom suggested that protection against hospitalization after two doses of vaccine was well maintained.<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="body-ref-r19-3" href-manipulated="true" aria-label="Reference 19">19</a></sup></div><div role="paragraph">These findings are consistent with neutralization data for the omicron variant. South African, German, and U.K. studies indicate a reduction in neutralizing activity by a factor of 20 to 40 in serum specimens obtained from recipients of two doses of BNT162b2 as compared with neutralization against early pandemic viruses and by a factor of at least 10 as compared with neutralization against the delta variant.<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3 r4 r5 r34" id="body-ref-r34-1" href-manipulated="true">3–5,34</a></sup> In serum specimens obtained from recipients of two doses of ChAdOx1 nCoV-19, a greater reduction in neutralizing activity was observed, with a high proportion of postvaccination serum samples having neutralizing activity below the limit of quantification in the assay.<sup><a href="#core-r34" role="doc-biblioref" data-xml-rid="r34" id="body-ref-r34-2" href-manipulated="true" aria-label="Reference 34">34</a></sup> Higher neutralizing activity was observed after a booster dose.<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3 r4 r34" id="body-ref-r34-3" href-manipulated="true">3,4,34</a></sup></div><div role="paragraph">Although a correlation between neutralizing antibody levels and vaccine effectiveness against symptomatic SARS-CoV-2 infection has been observed at a population level,<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6-2" href-manipulated="true" aria-label="Reference 6">6</a></sup> a similar correlation with effectiveness against severe disease is much less certain. With previous variants, vaccine effectiveness against severe disease, including hospitalization and death, has been higher and has been retained for a longer period than effectiveness against mild disease.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16 r19" id="body-ref-r19-4" href-manipulated="true">16,19</a></sup> Cellular immune responses are likely to play a relatively more important role in protection as antibodies wane with time since infection or vaccination; antibody waning may increase the risk of SARS-CoV-2 infection even as cellular immunity probably limits progression to severe disease.<sup><a href="#core-r35" role="doc-biblioref" data-xml-rid="r35" id="body-ref-r35-1" href-manipulated="true" aria-label="Reference 35">35</a></sup> Cellular immunity is also likely to play an important role in protection against SARS-CoV-2 variants.<sup><a href="#core-r35" role="doc-biblioref" data-xml-rid="r35" id="body-ref-r35-2" href-manipulated="true" aria-label="Reference 35">35</a></sup> Estimating effectiveness against severe disease caused by the omicron variant will follow a lag; however, on the basis of experience with other variants and early estimates of hospitalization rates, vaccine effectiveness against severe disease is likely to be substantially higher than the estimates against symptomatic disease.<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19 r36" id="body-ref-r36" href-manipulated="true">19,36</a></sup></div><div role="paragraph">The populations that have received different vaccines as a primary course are different. For example, ChAdOx1 nCoV-19 was the main vaccine used early in the program in care homes and among persons in clinical risk groups. Furthermore, mRNA vaccines were the main vaccines used in persons younger than 40 years of age after the reported association between ChAdOx1 nCoV-19 and vaccine-induced thrombotic thrombocytopenia.<sup><a href="#core-r37" role="doc-biblioref" data-xml-rid="r37" id="body-ref-r37" href-manipulated="true" aria-label="Reference 37">37</a></sup> Although adjustments were made for age and clinical risk factors, these age differences may explain some of the differences in the findings for the primary course — for example, the high vaccine effectiveness against omicron 2 to 9 weeks after the second dose of BNT162b2 is likely to be primarily among recently vaccinated young adults and teenagers. Differences are also noted in populations that have received a booster dose as compared with those who have received only two doses, with the former skewed toward older populations with more coexisting conditions. Persons who have not yet received a booster could have missed the boost for reasons that may be associated with exposure risk; for example, booster vaccination may have been delayed owing to an outbreak in a closed setting. The analysis with ChAdOx1 nCoV-19 boosters is particularly likely to be subject to bias because this vaccine was not recommended as a booster in the United Kingdom; therefore, some misclassification may have occurred, and persons who received ChAdOx1 nCoV-19 are likely to have done so because of contraindications to other vaccines.</div><div role="paragraph">The large scale of testing and sequencing in the United Kingdom, as well as the use of a national vaccination register, has enabled rapid evaluation of vaccine effectiveness against symptomatic infection with the omicron variant. Nevertheless, the study has some limitations, and findings should be interpreted with caution. During this early period of circulation of the new variant, a large proportion of cases occurred among travelers. Persons who reported foreign travel in the preceding 2 weeks were excluded from this analysis; however, not all travelers may have been excluded, and contacts of travelers will not have been identified. This group is likely to have different exposure than the wider population and may also have different levels of vaccine coverage. Therefore, residual confounding may be present. Owing to the relatively small number of omicron cases in the United Kingdom, our estimates are subject to considerable uncertainty, and we are unable to break down estimates according to population characteristics that may affect vaccine effectiveness (e.g., age and clinical risk group).<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="body-ref-r19-6" href-manipulated="true" aria-label="Reference 19">19</a></sup></div><div role="paragraph">In this analysis, our comparator group is unvaccinated persons, who make up a very small proportion of persons in several age cohorts. These persons are likely to differ from the general population according to characteristics that could confound our estimates of vaccine effectiveness. In this analysis that covers all ages, this type of confounding may be less of an issue than in analyses restricted to elderly populations. Furthermore, recent analyses using different control groups have shown good concordance between analyses using an unvaccinated control group and analyses estimating relative vaccine effectiveness among persons who have received a booster dose as compared with those who have received two doses. Booster doses have only recently been rolled out in England; therefore, we are able to estimate vaccine effectiveness for only a short period after booster vaccination, and we do not have information on the duration of protection after a booster dose. Some misclassification may also have occurred owing to both imperfect sensitivity and specificity of PCR testing, as well as the use of <i>S</i> target–negative status to identify omicron cases.</div><div role="paragraph">Our findings indicate that two doses of vaccination with BNT162b2 or ChAdOx1 nCoV-19 are insufficient to give adequate levels of protection against infection with the omicron variant and mild disease. Boosting with BNT162b2 or mRNA-1273 provided a substantial increase in protection against mild disease, although waning occurred over time. Boosters will probably offer even greater levels of protection against severe and fatal disease. Our findings support maximizing coverage with third doses of vaccine in highly vaccinated populations such as in the United Kingdom. Further follow-up will be needed to assess protection against severe disease and the duration of protection after booster vaccination.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="disclaimer" role="paragraph">Surveillance of coronavirus disease 2019 (Covid-19) testing and vaccination is undertaken under Regulation 3 of the Health Service (Control of Patient Information) Regulations 2002 to collect confidential patient information (<a href="https://www.legislation.gov.uk/uksi/2002/1438/regulation/3/made" target="_blank">www.legislation.gov.uk/uksi/2002/1438/regulation/3/made</a>) under Sections 3(i) (a) to (c), 3(i)(d) (i) and (ii), and 3. The study protocol was subject to an internal review by the Public Health England Research Ethics and Governance Group and was found to be fully compliant with all regulatory requirements. Given that no regulatory issues were identified and that ethics review is not a requirement for this type of work, it was decided that a full ethics review would not be necessary.</div><div data-type="published/updated" role="paragraph">This article was published on March 2, 2022, at NEJM.org.</div><div role="paragraph">Supported by the U.K. Health Security Agency (UKHSA). Dr. Simons is supported by a doctoral training grant from the Biotechnology and Biological Sciences Research Council (grant number BB/M009513/1).</div><div role="paragraph"><a href="#ap2">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank the UKHSA Covid-19 Data Science Team and the UKHSA Outbreak Surveillance Team and the staff of NHS England, NHS Digital, and NHS Test and Trace for their roles in developing and managing the Covid-19 testing, variant identification, and vaccination systems and data sets as well as the reporting NHS vaccinators and the staff of NHS laboratories, UKHSA laboratories, and lighthouse laboratories; the staff of the Wellcome Sanger Institute and other laboratories involved in whole-genome sequencing of Covid-19 samples; and the members of the Joint Committee on Vaccination and Immunisation and the U.K. Variant Technical Group for advice and feedback in developing this study.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2119451_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2119451/suppl_file/nejmoa2119451_appendix.pdf" download="nejmoa2119451_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2119451_appendix.pdf" data-doi="10.1056/NEJMoa2119451">Download</a></li><li>402.05 KB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2119451_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2119451/suppl_file/nejmoa2119451_disclosures.pdf" download="nejmoa2119451_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2119451_disclosures.pdf" data-doi="10.1056/NEJMoa2119451">Download</a></li><li>712.88 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern. November 26, 2021 (<a href="https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern">https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Classification+of+omicron+%28B.1.1.529%29%3A+SARS-CoV-2+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">European Centre for Disease Prevention and Control. Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (omicron) for the EU/EEA — first update. December 2, 2021 (<a href="https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Implications+of+the+further+emergence+and+spread+of+the+SARS-CoV-2+B.1.1.529+variant+of+concern+%28omicron%29+for+the+EU%2FEEA+%E2%80%94+first+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Cele S, Jackson L, Khoury DS, et al. SARS-CoV-2 omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. December 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3">https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+omicron+has+extensive+but+incomplete+escape+of+Pfizer+BNT162b2+elicited+neutralization+and+requires+ACE2+for+infection.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Wilhelm A, Widera M, Grikscheit K, et al. Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies. December 13, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v4">https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v4</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r4" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reduced+neutralization+of+SARS-CoV-2+omicron+variant+by+vaccine+sera+and+monoclonal+antibodies.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r4" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Huo J, Zhou D, et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. December 22, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2">https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron-B.1.1.529+leads+to+widespread+escape+from+neutralizing+antibody+responses.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. <em>Nat Med</em> 2021;27:1205-1211.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01377-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34002089/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000651469300002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing+antibody+levels+are+highly+predictive+of+immune+protection+from+symptomatic+SARS-CoV-2+infection.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=1205-1211&amp;doi=10.1038%2Fs41591-021-01377-8&amp;pmid=34002089" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] basis of these early laboratory findings. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r6-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] has been observed at a population level, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Addetia A, Crawford KHD, Dingens A, et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. <em>J Clin Microbiol</em> 2020;58(11):e02107-20-e02107-20.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JCM.02107-20" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32826322/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000582218400039" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing+antibodies+correlate+with+protection+from+SARS-CoV-2+in+humans+during+a+fishery+vessel+outbreak+with+a+high+attack+rate.&amp;publication_year=2020&amp;journal=J+Clin+Microbiol&amp;pages=e02107-20-e02107-20&amp;doi=10.1128%2FJCM.02107-20&amp;pmid=32826322" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Jeffery-Smith A, Rowland TAJ, Patel M, et al. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England. <em>Lancet Healthy Longev</em> 2021;2(12):e811-e819.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2666-7568(21)00253-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34873592/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reinfection+with+new+variants+of+SARS-CoV-2+after+natural+infection%3A+a+prospective+observational+cohort+in+13+care+homes+in+England.&amp;publication_year=2021&amp;journal=Lancet+Healthy+Longev&amp;pages=e811-e819&amp;doi=10.1016%2FS2666-7568%2821%2900253-1&amp;pmid=34873592" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_10_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <em>Lancet</em> 2021;397:99-111.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(20)32661-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33306989/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000607269000027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+ChAdOx1+nCoV-19+vaccine+%28AZD1222%29+against+SARS-CoV-2%3A+an+interim+analysis+of+four+randomised+controlled+trials+in+Brazil%2C+South+Africa%2C+and+the+UK.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=99-111&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;pmid=33306989" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_12_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. <em>BMJ</em> 2021;373:n1088-n1088.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.n1088" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33985964/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000652650700008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+Pfizer-BioNTech+and+Oxford-AstraZeneca+vaccines+on+covid-19+related+symptoms%2C+hospital+admissions%2C+and+mortality+in+older+adults+in+England%3A+test+negative+case-control+study.&amp;publication_year=2021&amp;journal=BMJ&amp;pages=n1088-n1088&amp;doi=10.1136%2Fbmj.n1088&amp;pmid=33985964" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. <em>Lancet</em> 2021;397:1725-1735.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00790-X" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33901423/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647813600027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+coverage+in+health-care+workers+in+England+and+effectiveness+of+BNT162b2+mRNA+vaccine+against+infection+%28SIREN%29%3A+a+prospective%2C+multicentre%2C+cohort+study.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1725-1735&amp;doi=10.1016%2FS0140-6736%2821%2900790-X&amp;pmid=33901423" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — eight U.S. locations, December 2020–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:495-500.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7013e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33793460/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000636784900007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+vaccine+effectiveness+of+BNT162b2+and+mRNA-1273+COVID-19+vaccines+in+preventing+SARS-CoV-2+infection+among+health+care+personnel%2C+first+responders%2C+and+other+essential+and+frontline+workers+%E2%80%94+eight+U.S.+locations%2C+December+2020%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=495-500&amp;doi=10.15585%2Fmmwr.mm7013e3&amp;pmid=33793460" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. <em>N Engl J Med</em> 2021;384:1412-1423.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_16_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2101765&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640554500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+mRNA+Covid-19+vaccine+in+a+nationwide+mass+vaccination+setting.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1412-1423&amp;doi=10.1056%2FNEJMoa2101765&amp;pmid=33626250" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r16" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_17_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r16" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] than effectiveness against mild disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant. <em>N Engl J Med</em> 2021;385:585-594.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r17" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_18_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2108891&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34289274/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000675554200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Covid-19+vaccines+against+the+B.1.617.2+%28delta%29+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=585-594&amp;doi=10.1056%2FNEJMoa2108891&amp;pmid=34289274" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r17" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] in persons 18 years of age or older. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Pouwels KB, Pritchard E, Matthews PC, et al. Impact of delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. August 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1">https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r19-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+delta+on+viral+burden+and+vaccine+effectiveness+against+new+SARS-CoV-2+infections+in+the+UK.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Andrews N, Tessier E, Stowe J, et al. Duration of protection against mild and severe disease by Covid-19 vaccines. <em>N Engl J Med</em> 2022;386:340-350.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_20_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2115481&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/35021002/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000741666000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Duration+of+protection+against+mild+and+severe+disease+by+Covid-19+vaccines.&amp;publication_year=2022&amp;journal=N+Engl+J+Med&amp;pages=340-350&amp;doi=10.1056%2FNEJMoa2115481&amp;pmid=35021002" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] against both mild and severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] two doses of vaccine was well maintained. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] than effectiveness against mild disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r36" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the estimates against symptomatic disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] (e.g., age and clinical risk group). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Tada T, Zhou H, Dcosta BM, Samanovic MI, Mulligan MJ, Landau NR. Partial resistance of SARS-CoV-2 delta variants to vaccine-elicited antibodies and convalescent sera. <em>iScience</em> 2021;24(11):103341-103341.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.isci.2021.103341" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34723159/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000730163700011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Partial+resistance+of+SARS-CoV-2+delta+variants+to+vaccine-elicited+antibodies+and+convalescent+sera.&amp;publication_year=2021&amp;journal=iScience&amp;pages=103341-103341&amp;doi=10.1016%2Fj.isci.2021.103341&amp;pmid=34723159" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Goldberg Y, Mandel M, Bar-On YM, et al. Waning immunity of the BNT162b2 vaccine: a nationwide study from Israel. August 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1">https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Waning+immunity+of+the+BNT162b2+vaccine%3A+a+nationwide+study+from+Israel.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">Israel A, Merzon E, Schäffer AA, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. August 5, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1">https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Elapsed+time+since+BNT162b2+vaccine+and+risk+of+SARS-CoV-2+infection+in+a+large+cohort.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Mizrahi B, Lotan R, Kalkstein N, et al. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine: preliminary study. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1">https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+SARS-CoV-2+breakthrough+infections+to+time-from-vaccine%3A+preliminary+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">Andrews N, Stowe J, Kirsebom F, Gower C, Ramsay M, Lopez Bernal J. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study. November 15, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.11.15.21266341v1">https://www.medrxiv.org/content/10.1101/2021.11.15.21266341v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+BNT162b2+%28Comirnaty%2C+Pfizer-BioNTech%29+COVID-19+booster+vaccine+against+covid-19+related+symptoms+in+England%3A+test+negative+case-control+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="r25" class="citations"><div class="citation"><div class="citation-content">Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. <em>N Engl J Med</em> 2021;385:1393-1400.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_26_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2114255&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34525275/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696036600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Protection+of+BNT162b2+vaccine+booster+against+Covid-19+in+Israel.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1393-1400&amp;doi=10.1056%2FNEJMoa2114255&amp;pmid=34525275" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="r26" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: omicron VOC-21NOV-01 (B.1.1.529) update on cases, S gene target failure and risk assessment. December 8, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r26" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+omicron+VOC-21NOV-01+%28B.1.1.529%29+update+on+cases%2C+S+gene+target+failure+and+risk+assessment&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r26" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] was apparent beginning in late November. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] target–positive result. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="r27" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. COVID-19 vaccine surveillance report: week 49. 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039677/Vaccine_surveillance_report_-_week_49.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039677/Vaccine_surveillance_report_-_week_49.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r27"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+surveillance+report%3A+week+49&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="r28" class="citations"><div class="citation"><div class="citation-content">Department of Health &amp; Social Care. JCVI advice on the UK vaccine response to the omicron variant. Independent report. November 29, 2021 (<a href="https://www.gov.uk/government/publications/uk-vaccine-response-to-the-omicron-variant-jcvi-advice/jcvi-advice-on-the-uk-vaccine-response-to-the-omicron-variant">https://www.gov.uk/government/publications/uk-vaccine-response-to-the-omicron-variant-jcvi-advice/jcvi-advice-on-the-uk-vaccine-response-to-the-omicron-variant</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=JCVI+advice+on+the+UK+vaccine+response+to+the+omicron+variant.+Independent+report&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="r29" class="citations"><div class="citation"><div class="citation-content">NHS England. National COVID-19 and flu vaccination programmes. 2021 (<a href="https://www.england.nhs.uk/contact-us/privacy-notice/national-flu-vaccination-programme/">https://www.england.nhs.uk/contact-us/privacy-notice/national-flu-vaccination-programme/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r29"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=National+COVID-19+and+flu+vaccination+programmes&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="r30" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. COVID-19: the green book, chapter 14a: coronavirus (COVID-19) vaccination information for public health professionals. 2020 (<a href="https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a">https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r30"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19%3A+the+green+book%2C+chapter+14a%3A+coronavirus+%28COVID-19%29+vaccination+information+for+public+health+professionals&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="r31" class="citations"><div class="citation"><div class="citation-content">NHS Digital. COVID-19 — high risk shielded patient list identification methodology. 2020 (<a href="https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology/rule-logic">https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology/rule-logic</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r31"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+%E2%80%94+high+risk+shielded+patient+list+identification+methodology&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="r32" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: variant of concern: omicron, VOC-21NOV-01 (B.1.1.529). Technical briefing 30. December 3, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038404/Technical_Briefing_30.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038404/Technical_Briefing_30.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+variant+of+concern%3A+omicron%2C+VOC-21NOV-01+%28B.1.1.529%29.+Technical+briefing+30&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="r33" class="citations"><div class="citation"><div class="citation-content">Public Health England, GitHub. Stardardised variant definitions. 2021 (<a href="https://github.com/phe-genomics/variant_definitions">https://github.com/phe-genomics/variant_definitions</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Stardardised+variant+definitions&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="r34" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 31. December 10, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1042367/technical_briefing-31-10-december-2021.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1042367/technical_briefing-31-10-december-2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r34" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England.+Technical+briefing+31&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r34" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] the limit of quantification in the assay. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="r35" class="citations"><div class="citation"><div class="citation-content">Goel RR, Painter MM, Apostolidis SA, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. <em>Science</em> 2021;374(6572):abm0829-abm0829.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r35" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm0829" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34648302/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000728578700050" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=mRNA+vaccines+induce+durable+immune+memory+to+SARS-CoV-2+and+variants+of+concern.&amp;publication_year=2021&amp;journal=Science&amp;pages=abm0829-abm0829&amp;doi=10.1126%2Fscience.abm0829&amp;pmid=34648302" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r35" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r35-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] limits progression to severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r35-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] in protection against SARS-CoV-2 variants. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="r36" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 34. January 14, 2022 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England.+Technical+briefing+34&amp;publication_year=2022" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">37.</div><div id="r37" class="citations"><div class="citation"><div class="citation-content">Pavord S, Scully M, Hunt BJ, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. <em>N Engl J Med</em> 2021;385:1680-1689.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r37"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_38_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2109908&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34379914/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685293800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+features+of+vaccine-induced+immune+thrombocytopenia+and+thrombosis.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1680-1689&amp;doi=10.1056%2FNEJMoa2109908&amp;pmid=34379914" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/386/16"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">386</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">16</span></span> • <span property="datePublished">April 21, 2022</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">1532</span>-<span property="pageEnd">1546</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2022 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: March 2, 2022</div><div><b class="core-label">Published in issue</b>: April 21, 2022</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/viral-infections" alt="View article keyword Viral Infections" data-interactiontype="article_recirculation_click">Viral Infections</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Nick</span> <span property="familyName">Andrews</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Julia</span> <span property="familyName">Stowe</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Freja</span> <span property="familyName">Kirsebom</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Samuel</span> <span property="familyName">Toffa</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Tim</span> <span property="familyName">Rickeard</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Eileen</span> <span property="familyName">Gallagher</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Charlotte</span> <span property="familyName">Gower</span>, <span property="honorificSuffix">D.Phil.</span></span>, <span property="author" typeof="Person"><span property="givenName">Meaghan</span> <span property="familyName">Kall</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Natalie</span> <span property="familyName">Groves</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Anne-Marie</span> <span property="familyName">O’Connell</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">David</span> <span property="familyName">Simons</span>, <span property="honorificSuffix">M.B., B.S.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9655-1656" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-9655-1656</a></span>, <span property="author" typeof="Person"><span property="givenName">Paula B.</span> <span property="familyName">Blomquist</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Asad</span> <span property="familyName">Zaidi</span>, <span property="honorificSuffix">M.Sc.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6420-2539" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-6420-2539</a></span>, <span property="author" typeof="Person"><span property="givenName">Sophie</span> <span property="familyName">Nash</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Nurin</span> <span property="familyName">Iwani Binti Abdul Aziz</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Simon</span> <span property="familyName">Thelwall</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gavin</span> <span property="familyName">Dabrera</span>, <span property="honorificSuffix">M.B., B.S., F.F.P.H.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4606-5945" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-4606-5945</a></span>, <span property="author" typeof="Person"><span property="givenName">Richard</span> <span property="familyName">Myers</span>, <span property="honorificSuffix">M.R.C.P.C.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gayatri</span> <span property="familyName">Amirthalingam</span>, <span property="honorificSuffix">M.F.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Saheer</span> <span property="familyName">Gharbia</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jeffrey C.</span> <span property="familyName">Barrett</span>, <span property="honorificSuffix">D.Phil.</span></span>, <span property="author" typeof="Person"><span property="givenName">Richard</span> <span property="familyName">Elson</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Shamez N.</span> <span property="familyName">Ladhani</span>, <span property="honorificSuffix">Ph.D., M.R.C.P.C.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Neil</span> <span property="familyName">Ferguson</span>, <span property="honorificSuffix">D.Phil.</span></span>, <span property="author" typeof="Person"><span property="givenName">Maria</span> <span property="familyName">Zambon</span>, <span property="honorificSuffix">Ph.D., F.R.C.Path.</span></span>, <span property="author" typeof="Person"><span property="givenName">Colin N.J.</span> <span property="familyName">Campbell</span>, <span property="honorificSuffix">M.P.H., F.F.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Kevin</span> <span property="familyName">Brown</span>, <span property="honorificSuffix">M.R.C.P., F.R.C.Path.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1568-683X" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1568-683X</a></span>, <span property="author" typeof="Person"><span property="givenName">Susan</span> <span property="familyName">Hopkins</span>, <span property="honorificSuffix">F.R.C.P., F.F.P.H.</span></span>, <span property="author" typeof="Person"><span property="givenName">Meera</span> <span property="familyName">Chand</span>, <span property="honorificSuffix">M.R.C.P., F.R.C.Path.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mary</span> <span property="familyName">Ramsay</span>, <span property="honorificSuffix">M.B., B.S., F.F.P.H.</span></span>, and <span property="author" typeof="Person"><span property="givenName">Jamie</span> <span property="familyName">Lopez Bernal</span>, <span property="honorificSuffix">Ph.D., M.B., B.S.</span></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From the U.K. Health Security Agency (N.A., J.S., F.K., S. Toffa, T.R., E.G., C.G., M.K., N.G., A.-M.O., D.S., P.B.B., A.Z., S.N., N.I.B.A.A., S. Thelwall, G.D., R.M., G.A., S.G., R.E., S.N.L., M.Z., C.N.J.C., K.B., S.H., M.C., M.R., J.L.B.), the National Institute for Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine (N.A., G.A., C.N.J.C., K.B., M.R., J.L.B.), the Paediatric Infectious Diseases Research Group, St. George’s University of London (R.M., S.N.L.), the Medical Research Council Centre for Global Infectious Disease Analysis (N.F.) and the NIHR Health Protection Research Unit in Respiratory Infections (N.F., M.Z., J.L.B.), Imperial College London, and Guy’s and St. Thomas’s Hospital NHS Trust (M.C.), London, Wellcome Sanger Institute, Hinxton (J.C.B.), and Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford (S.H.) — all in the United Kingdom.</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Lopez Bernal can be contacted at <a href="mailto:jamie.lopezbernal2@phe.gov.uk">jamie.lopezbernal2@phe.gov.uk</a> or at the U.K. Health Security Agency, 61 Colindale Ave., London, NW9 5EQ, United Kingdom.</div><div role="doc-footnote"><div id="fn1" role="paragraph">Drs. Andrews and Stowe contributed equally to this article.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">1656</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2119451" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="38e27800-92dc-42cd-9643-2b7020165c6f"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384" style="display:inline-block;">
                <img alt="Article has an altmetric score of 5433" src="https://badges.altmetric.com/?size=320&amp;score=5433&amp;types=mbvrtfud" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_38e27800-92dc-42cd-9643-2b7020165c6f" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=news">
          Picked up by <b>276</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=blogs">
          Blogged by <b>15</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #9f79f2;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=policy-documents">
          Referenced in <b>3</b> policy sources
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=twitter">
          Posted by <b>5948</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #f27700;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=patents">
          Referenced in <b>2</b> patents
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=facebook">
          On <b>6</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=wikipedia">
          Referenced in <b>1</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=reddit">
          Reddited by <b>9</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #94DB5E;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=video">
          On <b>2</b> videos
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #70B1FF;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123949384&amp;tab=bluesky">
          Referenced by <b>3</b> Bluesky users
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>1186</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6cd48a141aecc-GRU"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2119451"> <input type="hidden" name="downloadFileName" value="csp_386_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2119451%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-16%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="1656" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Solana Narum, </li><li class="list-inline-item cited-by__entry__author">Thibault Stalder, </li><li class="list-inline-item cited-by__entry__author">Benjamin Ridenhour, </li><li class="list-inline-item cited-by__entry__author">Erik R. Coats, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 surveillance of wastewater in small rural communities identifies lack of vaccine coverage as influence of omicron outbreak, </span><span class="cited-by__entry__series-title">Water Research, </span><span class="cited-by__entry__volume"><strong>283</strong>, </span><span class="cited-by__entry__page-range">(123818), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.watres.2025.123818" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.watres.2025.123818</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.watres.2025.123818" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Warawut Chaiwong, </li><li class="list-inline-item cited-by__entry__author">Nuchjira Takheaw, </li><li class="list-inline-item cited-by__entry__author">Witida Laopajon, </li><li class="list-inline-item cited-by__entry__author">Chote Nisoong, </li><li class="list-inline-item cited-by__entry__author">Supansa Pata, </li><li class="list-inline-item cited-by__entry__author">Pilaiporn Duangjit, </li><li class="list-inline-item cited-by__entry__author">Juthamas Inchai, </li><li class="list-inline-item cited-by__entry__author">Chaicharn Pothirat, </li><li class="list-inline-item cited-by__entry__author">Chaiwat Bumroongkit, </li><li class="list-inline-item cited-by__entry__author">Athavudh Deesomchok, </li><li class="list-inline-item cited-by__entry__author">Theerakorn Theerakittikul, </li><li class="list-inline-item cited-by__entry__author">Atikun Limsukon, </li><li class="list-inline-item cited-by__entry__author">Pattraporn Tajarernmuang, </li><li class="list-inline-item cited-by__entry__author">Nutchanok Niyatiwatchanchai, </li><li class="list-inline-item cited-by__entry__author">Konlawij Trongtrakul, </li><li class="list-inline-item cited-by__entry__author">Watchara Kasinrerk, </li><li class="list-inline-item cited-by__entry__author">Chalerm Liwsrisakun, </li></ul><span class="cited-by__entry__title">Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>61</strong>, </span><span class="cited-by__entry__page-range">(127330), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127330" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127330</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127330" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Eleanor Burch, </li><li class="list-inline-item cited-by__entry__author">Hannah Christensen, </li><li class="list-inline-item cited-by__entry__author">Ellen Brooks-Pollock, </li></ul><span class="cited-by__entry__title">The effect of outcome choice on vaccine dose allocation: a modelling study, </span><span class="cited-by__entry__series-title">Journal of Theoretical Biology, </span><span class="cited-by__entry__volume"><strong>610</strong>, </span><span class="cited-by__entry__page-range">(112156), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jtbi.2025.112156" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jtbi.2025.112156</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jtbi.2025.112156" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Naoki Kawai, </li><li class="list-inline-item cited-by__entry__author">Hideyuki Ikematsu, </li><li class="list-inline-item cited-by__entry__author">Takuma Bando, </li><li class="list-inline-item cited-by__entry__author">Woon Joo Lee, </li><li class="list-inline-item cited-by__entry__author">Shinro Matsuura, </li><li class="list-inline-item cited-by__entry__author">Maeda Tetsunari, </li><li class="list-inline-item cited-by__entry__author">Mariko Echizen, </li><li class="list-inline-item cited-by__entry__author">Takashi Kawashima, </li></ul><span class="cited-by__entry__title">Comparison of adverse reactions to COVID-19 XBB.1.5 and influenza vaccination in the 2023-24 Japanese influenza season, </span><span class="cited-by__entry__series-title">Journal of Infection and Chemotherapy, </span><span class="cited-by__entry__volume"><strong>31</strong>, </span><span class="cited-by__entry__issue">8, </span><span class="cited-by__entry__page-range">(102728), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jiac.2025.102728" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jiac.2025.102728</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jiac.2025.102728" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Adeyemi Okunogbe, </li><li class="list-inline-item cited-by__entry__author">Donal Bisanzio, </li><li class="list-inline-item cited-by__entry__author">Garrison Spencer, </li><li class="list-inline-item cited-by__entry__author">Shradha Chhabria, </li><li class="list-inline-item cited-by__entry__author">Jaynaide Powis, </li><li class="list-inline-item cited-by__entry__author">Rachel Nugent, </li></ul><span class="cited-by__entry__title">The economic impacts of COVID-19 hospitalizations, intensive care unit admissions, and deaths related to overweight and obesity, </span><span class="cited-by__entry__series-title">PLOS Global Public Health, </span><span class="cited-by__entry__volume"><strong>5</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(e0001445), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1371/journal.pgph.0001445" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1371/journal.pgph.0001445</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1371/journal.pgph.0001445" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Andrea L. Schaffer, </li><li class="list-inline-item cited-by__entry__author">William J. Hulme, </li><li class="list-inline-item cited-by__entry__author">Elsie Horne, </li><li class="list-inline-item cited-by__entry__author">Edward P.K. Parker, </li><li class="list-inline-item cited-by__entry__author">Venexia Walker, </li><li class="list-inline-item cited-by__entry__author">Catherine Stables, </li><li class="list-inline-item cited-by__entry__author">Amir Mehrkar, </li><li class="list-inline-item cited-by__entry__author">Seb C.J. Bacon, </li><li class="list-inline-item cited-by__entry__author">Chris Bates, </li><li class="list-inline-item cited-by__entry__author">Ben Goldacre, </li><li class="list-inline-item cited-by__entry__author">Alex J. Walker, </li><li class="list-inline-item cited-by__entry__author">Miguel A. Hernán, </li><li class="list-inline-item cited-by__entry__author">Jonathan A.C. Sterne, </li></ul><span class="cited-by__entry__title">Effect of the 2022 COVID-19 booster vaccination campaign in people aged 50&nbsp;years in England: Regression discontinuity analysis in OpenSAFELY-TPP, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>59</strong>, </span><span class="cited-by__entry__page-range">(127257), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.127257" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.127257</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.127257" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Chiranjib Chakraborty, </li><li class="list-inline-item cited-by__entry__author">Yi-Hao Lo, </li><li class="list-inline-item cited-by__entry__author">Manojit Bhattacharya, </li><li class="list-inline-item cited-by__entry__author">Arpita Das, </li><li class="list-inline-item cited-by__entry__author">Zhi-Hong Wen, </li></ul><span class="cited-by__entry__title">Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development, </span><span class="cited-by__entry__series-title">Molecular Therapy Nucleic Acids, </span><span class="cited-by__entry__volume"><strong>36</strong>, </span><span class="cited-by__entry__issue">2, </span><span class="cited-by__entry__page-range">(102527), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.omtn.2025.102527" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.omtn.2025.102527</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.omtn.2025.102527" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Sabina Yasmin, </li><li class="list-inline-item cited-by__entry__author">Mohammad Yousuf Ansari, </li></ul><span class="cited-by__entry__title">A detailed examination of coronavirus disease 2019 (COVID-19): Covering past and future perspectives, </span><span class="cited-by__entry__series-title">Microbial Pathogenesis, </span><span class="cited-by__entry__volume"><strong>203</strong>, </span><span class="cited-by__entry__page-range">(107398), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.micpath.2025.107398" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.micpath.2025.107398</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.micpath.2025.107398" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Linda S. Gutierrez, </li><li class="list-inline-item cited-by__entry__author">Kate S. Brien, </li><li class="list-inline-item cited-by__entry__author">Walter Faig, </li><li class="list-inline-item cited-by__entry__author">Carmelita Whitfield, </li><li class="list-inline-item cited-by__entry__author">Susannah Anderson, </li><li class="list-inline-item cited-by__entry__author">Sarah Bauerle Bass, </li><li class="list-inline-item cited-by__entry__author">Stella Winters, </li><li class="list-inline-item cited-by__entry__author">Charlotte A. Moser, </li><li class="list-inline-item cited-by__entry__author">Barbara J. Kuter, </li></ul><span class="cited-by__entry__title">University Students' understanding of masking policies and their mask use in relation to COVID-19 vaccination history, both in and out of the classroom, during the pandemic, 2022–2023, </span><span class="cited-by__entry__series-title">Vaccine: X, </span><span class="cited-by__entry__volume"><strong>24</strong>, </span><span class="cited-by__entry__page-range">(100636), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jvacx.2025.100636" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jvacx.2025.100636</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jvacx.2025.100636" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Nadine Glaser, </li><li class="list-inline-item cited-by__entry__author">Sophie Diexer, </li><li class="list-inline-item cited-by__entry__author">Bianca Klee, </li><li class="list-inline-item cited-by__entry__author">Janka Massag, </li><li class="list-inline-item cited-by__entry__author">Laura R. Pfrommer, </li><li class="list-inline-item cited-by__entry__author">Oliver Purschke, </li><li class="list-inline-item cited-by__entry__author">Mascha Binder, </li><li class="list-inline-item cited-by__entry__author">Thomas Frese, </li><li class="list-inline-item cited-by__entry__author">Matthias Girndt, </li><li class="list-inline-item cited-by__entry__author">Jessica I. Hoell, </li><li class="list-inline-item cited-by__entry__author">Irene Moor, </li><li class="list-inline-item cited-by__entry__author">Jonas Rosendahl, </li><li class="list-inline-item cited-by__entry__author">Michael Gekle, </li><li class="list-inline-item cited-by__entry__author">Daniel Sedding, </li><li class="list-inline-item cited-by__entry__author">Cornelia Gottschick, </li><li class="list-inline-item cited-by__entry__author">Rafael Mikolajczyk, </li></ul><span class="cited-by__entry__title">Duration of mild acute SARS-CoV-2 infections with Omicron depending on previous vaccinations and infections – Using data of the German DigiHero cohort study from post-pandemic winters 2022/2023 and 2023/2024, </span><span class="cited-by__entry__series-title">Journal of Infection and Public Health, </span><span class="cited-by__entry__volume"><strong>18</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(102746), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jiph.2025.102746" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jiph.2025.102746</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jiph.2025.102746" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2119451%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-16%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2119451" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2119451" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119451.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119451_f1.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/d2f1d981-336f-4a21-bbe3-ef0a852a2d2a/assets/images/large/nejmoa2119451_f1.jpg" height="3438" width="2456" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants, According to the Period after the Second and Booster Doses.</div><div class="notes"><div role="doc-footnote">B.1.617.2 is the delta variant, and B.1.1.529 the omicron variant, of the severe acute respiratory syndrome coronavirus 2. 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119451_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2119451/asset/9c22b731-3ec9-4757-8186-a8b71a2d7a38/assets/images/large/nejmoa2119451_t1.jpg" height="3438" width="1480" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Characteristic</th><th class="txxx-borders">Overall<br>(N=2,663,549)</th><th class="txxx-borders">Test-Negative Status<br>(N=1,572,621)</th><th class="txxx-borders">Delta Variant<br>(N=204,154)</th><th class="txxr-borders">Omicron Variant<br>(N=886,774)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row" data-xml-valign="bottom"><td class="xxlx-borders shading" data-xml-align="left">Percent of all participants</td><td class="xxxx-borders shading">100</td><td class="xxxx-borders shading">59.0</td><td class="xxxx-borders shading">7.7</td><td class="xxxr-borders shading">33.3</td></tr><tr data-type="row"><td class="xxlx-borders">Sex — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Female</td><td class="xxxx-borders shading">1,555,857 (58.4)</td><td class="xxxx-borders shading">955,508 (60.8)</td><td class="xxxx-borders shading">111,080 (54.4)</td><td class="xxxr-borders shading">489,269 (55.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Male</td><td class="xxxx-borders">1,102,797 (41.4)</td><td class="xxxx-borders">614,068 (39.0)</td><td class="xxxx-borders">92,764 (45.4)</td><td class="xxxr-borders">395,965 (44.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Missing data</td><td class="xxxx-borders shading">4,895 (0.2)</td><td class="xxxx-borders shading">3,045 (0.2)</td><td class="xxxx-borders shading">310 (0.2)</td><td class="xxxr-borders shading">1,540 (0.2)</td></tr><tr data-type="row"><td class="xxlx-borders">Age — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">18 or 19 yr</td><td class="xxxx-borders shading">86,559 (3.2)</td><td class="xxxx-borders shading">46,445 (3.0)</td><td class="xxxx-borders shading">4,055 (2.0)</td><td class="xxxr-borders shading">36,059 (4.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">20–24 yr</td><td class="xxxx-borders">279,465 (10.5)</td><td class="xxxx-borders">151,700 (9.6)</td><td class="xxxx-borders">14,071 (6.9)</td><td class="xxxr-borders">113,694 (12.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">25–29 yr</td><td class="xxxx-borders shading">336,504 (12.6)</td><td class="xxxx-borders shading">192,568 (12.2)</td><td class="xxxx-borders shading">20,227 (9.9)</td><td class="xxxr-borders shading">123,709 (14.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">30–34 yr</td><td class="xxxx-borders">355,731 (13.4)</td><td class="xxxx-borders">212,628 (13.5)</td><td class="xxxx-borders">26,484 (13.0)</td><td class="xxxr-borders">116,619 (13.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">35–39 yr</td><td class="xxxx-borders shading">327,751 (12.3)</td><td class="xxxx-borders shading">197,453 (12.6)</td><td class="xxxx-borders shading">30,097 (14.7)</td><td class="xxxr-borders shading">100,201 (11.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">40–44 yr</td><td class="xxxx-borders">283,074 (10.6)</td><td class="xxxx-borders">164,907 (10.5)</td><td class="xxxx-borders">31,936 (15.6)</td><td class="xxxr-borders">86,231 (9.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">45–49 yr</td><td class="xxxx-borders shading">244,583 (9.2)</td><td class="xxxx-borders shading">140,024 (8.9)</td><td class="xxxx-borders shading">26,862 (13.2)</td><td class="xxxr-borders shading">77,697 (8.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">50–54 yr</td><td class="xxxx-borders">231,704 (8.7)</td><td class="xxxx-borders">136,899 (8.7)</td><td class="xxxx-borders">20,326 (10.0)</td><td class="xxxr-borders">74,479 (8.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">55–59 yr</td><td class="xxxx-borders shading">193,831 (7.3)</td><td class="xxxx-borders shading">117,764 (7.5)</td><td class="xxxx-borders shading">14,943 (7.3)</td><td class="xxxr-borders shading">61,124 (6.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">60–64 yr</td><td class="xxxx-borders">131,656 (4.9)</td><td class="xxxx-borders">84,101 (5.3)</td><td class="xxxx-borders">8,187 (4.0)</td><td class="xxxr-borders">39,368 (4.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">65–69 yr</td><td class="xxxx-borders shading">80,267 (3.0)</td><td class="xxxx-borders shading">53,952 (3.4)</td><td class="xxxx-borders shading">3,251 (1.6)</td><td class="xxxr-borders shading">23,064 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">70–74 yr</td><td class="xxxx-borders">55,598 (2.1)</td><td class="xxxx-borders">36,893 (2.3)</td><td class="xxxx-borders">1,846 (0.9)</td><td class="xxxr-borders">16,859 (1.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">75–79 yr</td><td class="xxxx-borders shading">30,615 (1.1)</td><td class="xxxx-borders shading">19,748 (1.3)</td><td class="xxxx-borders shading">976 (0.5)</td><td class="xxxr-borders shading">9,891 (1.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">80–84 yr</td><td class="xxxx-borders">15,333 (0.6)</td><td class="xxxx-borders">10,058 (0.6)</td><td class="xxxx-borders">488 (0.2)</td><td class="xxxr-borders">4,787 (0.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">85–89 yr</td><td class="xxxx-borders shading">7,452 (0.3)</td><td class="xxxx-borders shading">5,069 (0.3)</td><td class="xxxx-borders shading">279 (0.1)</td><td class="xxxr-borders shading">2,104 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">≥90 yr</td><td class="xxxx-borders">3,426 (0.1)</td><td class="xxxx-borders">2,412 (0.2)</td><td class="xxxx-borders">126 (0.1)</td><td class="xxxr-borders">888 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders shading">Race or ethnic group — no. (%)<a href="#core-t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">African</td><td class="xxxx-borders">39,865 (1.5)</td><td class="xxxx-borders">19,439 (1.2)</td><td class="xxxx-borders">1,851 (0.9)</td><td class="xxxr-borders">18,575 (2.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Caribbean</td><td class="xxxx-borders shading">23,070 (0.9)</td><td class="xxxx-borders shading">10,052 (0.6)</td><td class="xxxx-borders shading">1,527 (0.7)</td><td class="xxxr-borders shading">11,491 (1.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Another Black background</td><td class="xxxx-borders">3,955 (0.1)</td><td class="xxxx-borders">1,938 (0.1)</td><td class="xxxx-borders">241 (0.1)</td><td class="xxxr-borders">1,776 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Arab</td><td class="xxxx-borders shading">8,743 (0.3)</td><td class="xxxx-borders shading">5,271 (0.3)</td><td class="xxxx-borders shading">660 (0.3)</td><td class="xxxr-borders shading">2,812 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Bangladeshi</td><td class="xxxx-borders">18,372 (0.7)</td><td class="xxxx-borders">10,836 (0.7)</td><td class="xxxx-borders">1,231 (0.6)</td><td class="xxxr-borders">6,305 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Chinese</td><td class="xxxx-borders shading">17,803 (0.7)</td><td class="xxxx-borders shading">10,967 (0.7)</td><td class="xxxx-borders shading">1,142 (0.6)</td><td class="xxxr-borders shading">5,694 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Indian</td><td class="xxxx-borders">88,486 (3.3)</td><td class="xxxx-borders">57,385 (3.6)</td><td class="xxxx-borders">4,574 (2.2)</td><td class="xxxr-borders">26,527 (3.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Pakistani</td><td class="xxxx-borders shading">46,291 (1.7)</td><td class="xxxx-borders shading">27,417 (1.7)</td><td class="xxxx-borders shading">3,004 (1.5)</td><td class="xxxr-borders shading">15,870 (1.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Another Asian background</td><td class="xxxx-borders">34,867 (1.3)</td><td class="xxxx-borders">19,979 (1.3)</td><td class="xxxx-borders">2,082 (1.0)</td><td class="xxxr-borders">12,806 (1.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Mixed or multiple ethnic groups</td><td class="xxxx-borders shading">52,395 (2.0)</td><td class="xxxx-borders shading">29,291 (1.9)</td><td class="xxxx-borders shading">3,358 (1.6)</td><td class="xxxr-borders shading">19,746 (2.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">White</td><td class="xxxx-borders">2,215,756 (83.2)</td><td class="xxxx-borders">1,312,372 (83.5)</td><td class="xxxx-borders">176,390 (86.4)</td><td class="xxxr-borders">726,994 (82.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Another ethnic background</td><td class="xxxx-borders shading">18,302 (0.7)</td><td class="xxxx-borders shading">10,715 (0.7)</td><td class="xxxx-borders shading">1,180 (0.6)</td><td class="xxxr-borders shading">6,407 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Prefer not to say</td><td class="xxxx-borders">95,644 (3.6)</td><td class="xxxx-borders">56,959 (3.6)</td><td class="xxxx-borders">6,914 (3.4)</td><td class="xxxr-borders">31,771 (3.6)</td></tr><tr data-type="row"><td class="xxlx-borders shading">NHS region — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">East of England</td><td class="xxxx-borders">287,326 (10.8)</td><td class="xxxx-borders">191,259 (12.2)</td><td class="xxxx-borders">22,695 (11.1)</td><td class="xxxr-borders">73,372 (8.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">London</td><td class="xxxx-borders shading">411,785 (15.5)</td><td class="xxxx-borders shading">237,614 (15.1)</td><td class="xxxx-borders shading">24,571 (12.0)</td><td class="xxxr-borders shading">149,600 (16.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Midlands</td><td class="xxxx-borders">455,325 (17.1)</td><td class="xxxx-borders">280,909 (17.9)</td><td class="xxxx-borders">35,860 (17.6)</td><td class="xxxr-borders">138,556 (15.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">North East</td><td class="xxxx-borders shading">414,437 (15.6)</td><td class="xxxx-borders shading">232,576 (14.8)</td><td class="xxxx-borders shading">32,467 (15.9)</td><td class="xxxr-borders shading">149,394 (16.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">North West</td><td class="xxxx-borders">444,930 (16.7)</td><td class="xxxx-borders">207,429 (13.2)</td><td class="xxxx-borders">33,404 (16.4)</td><td class="xxxr-borders">204,097 (23.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">South East</td><td class="xxxx-borders shading">406,968 (15.3)</td><td class="xxxx-borders shading">257,588 (16.4)</td><td class="xxxx-borders shading">33,720 (16.5)</td><td class="xxxr-borders shading">115,660 (13.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">South West</td><td class="xxxx-borders">242,772 (9.1)</td><td class="xxxx-borders">165,240 (10.5)</td><td class="xxxx-borders">21,437 (10.5)</td><td class="xxxr-borders">56,095 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Missing</td><td class="xxxx-borders shading">6 (&lt;0.1)</td><td class="xxxx-borders shading">6 (&lt;0.1)</td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">0</td></tr><tr data-type="row"><td class="xxlx-borders">Index of multiple deprivation — no. (%)<a href="#core-t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">1</td><td class="xxxx-borders shading">482,884 (18.1)</td><td class="xxxx-borders shading">261,116 (16.6)</td><td class="xxxx-borders shading">37,433 (18.3)</td><td class="xxxr-borders shading">184,335 (20.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">2</td><td class="xxxx-borders">529,594 (19.9)</td><td class="xxxx-borders">305,748 (19.4)</td><td class="xxxx-borders">39,456 (19.3)</td><td class="xxxr-borders">184,390 (20.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">3</td><td class="xxxx-borders shading">540,303 (20.3)</td><td class="xxxx-borders shading">325,218 (20.7)</td><td class="xxxx-borders shading">41,308 (20.2)</td><td class="xxxr-borders shading">173,777 (19.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">4</td><td class="xxxx-borders">551,055 (20.7)</td><td class="xxxx-borders">333,456 (21.2)</td><td class="xxxx-borders">42,602 (20.9)</td><td class="xxxr-borders">174,997 (19.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">5</td><td class="xxxx-borders shading">550,254 (20.7)</td><td class="xxxx-borders shading">341,620 (21.7)</td><td class="xxxx-borders shading">42,756 (20.9)</td><td class="xxxr-borders shading">165,878 (18.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Missing data</td><td class="xxxx-borders">9,459 (0.4)</td><td class="xxxx-borders">5,463 (0.3)</td><td class="xxxx-borders">599 (0.3)</td><td class="xxxr-borders">3,397 (0.4)</td></tr><tr data-type="row"><td class="xxlx-borders shading">Previously tested positive — no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">No</td><td class="xxxx-borders">2,301,572 (86.4)</td><td class="xxxx-borders">1,312,548 (83.5)</td><td class="xxxx-borders">200,400 (98.2)</td><td class="xxxr-borders">788,624 (88.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Yes</td><td class="xxxx-borders shading">361,977 (13.6)</td><td class="xxxx-borders shading">260,073 (16.5)</td><td class="xxxx-borders shading">3,754 (1.8)</td><td class="xxxr-borders shading">98,150 (11.1)</td></tr><tr data-type="row"><td class="xxlx-borders">Vaccine priority group — no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Health and social care worker</td><td class="xxxx-borders shading">164,113 (6.2)</td><td class="xxxx-borders shading">113,183 (7.2)</td><td class="xxxx-borders shading">5,657 (2.8)</td><td class="xxxr-borders shading">45,273 (5.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Clinically extremely vulnerable</td><td class="xxxx-borders">142,002 (5.3)</td><td class="xxxx-borders">93,236 (5.9)</td><td class="xxxx-borders">7,443 (3.6)</td><td class="xxxr-borders">41,323 (4.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">At risk</td><td class="xxxx-borders shading">482,075 (18.1)</td><td class="xxxx-borders shading">307,240 (19.5)</td><td class="xxxx-borders shading">32,490 (15.9)</td><td class="xxxr-borders shading">142,345 (16.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12" data-xml-align="left">Severely immunosuppressed</td><td class="xbxx-borders">22,391 (0.8)</td><td class="xbxx-borders">13,985 (0.9)</td><td class="xbxx-borders">1,191 (0.6)</td><td class="xbxr-borders">7,215 (0.8)</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">B.1.617.2 is the delta variant, and B.1.1.529 the omicron variant, of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Percentages may not total 100 because of rounding.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">Race or ethnic group was determined from data in the National Immunisation Management System register.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">The index of multiple deprivation is a national indicator of level of deprivation on the basis of small geographic areas of residence; the index ranges from 1 (least deprived) to 5 (most deprived).</div></div></div></figcaption></a><figcaption><div class="caption">Characteristics of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t2"><figure class="table"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t2.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2119451/asset/04ef3106-41f7-4b58-8af9-62f2ac0f6cc9/assets/images/large/nejmoa2119451_t2.jpg" height="3438" width="1219" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Vaccination Status, Dose, and Interval after Vaccination</th><th class="txxx-borders">Overall<br>(N=2,663,549)</th><th class="txxx-borders">Test-Negative Status<br>(N=1,572,621)</th><th class="txxx-borders">Delta Variant<br>(N=204,154)</th><th class="txxr-borders">Omicron Variant<br>(N=886,774)</th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders">&nbsp;</td><th class="xxxr-borders" colspan="4"><span>number (percent)</span></th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging04 shading" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders shading">244,716 (9.2)</td><td class="xxxx-borders shading">107,238 (6.8)</td><td class="xxxx-borders shading">36,369 (17.8)</td><td class="xxxr-borders shading">101,109 (11.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0–3 wk</td><td class="xxxx-borders">64 (&lt;0.1)</td><td class="xxxx-borders">33 (&lt;0.1)</td><td class="xxxx-borders">8 (&lt;0.1)</td><td class="xxxr-borders">23 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥4 wk</td><td class="xxxx-borders shading">16,150 (0.6)</td><td class="xxxx-borders shading">8,470 (0.5)</td><td class="xxxx-borders shading">2,133 (1.0)</td><td class="xxxr-borders shading">5,547 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders shading">406 (&lt;0.1)</td><td class="xxxx-borders shading">224 (&lt;0.1)</td><td class="xxxx-borders shading">34 (&lt;0.1)</td><td class="xxxr-borders shading">148 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">740 (&lt;0.1)</td><td class="xxxx-borders">476 (&lt;0.1)</td><td class="xxxx-borders">28 (&lt;0.1)</td><td class="xxxr-borders">236 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">1,484 (0.1)</td><td class="xxxx-borders shading">894 (0.1)</td><td class="xxxx-borders shading">85 (&lt;0.1)</td><td class="xxxr-borders shading">505 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">2,700 (0.1)</td><td class="xxxx-borders">1,659 (0.1)</td><td class="xxxx-borders">274 (0.1)</td><td class="xxxr-borders">767 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">17,775 (0.7)</td><td class="xxxx-borders shading">10,788 (0.7)</td><td class="xxxx-borders shading">4,013 (2.0)</td><td class="xxxr-borders shading">2,974 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">120,979 (4.5)</td><td class="xxxx-borders">68,757 (4.4)</td><td class="xxxx-borders">29,100 (14.3)</td><td class="xxxr-borders">23,122 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">292,794 (11.0)</td><td class="xxxx-borders shading">147,721 (9.4)</td><td class="xxxx-borders shading">46,103 (22.6)</td><td class="xxxr-borders shading">98,970 (11.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders shading">102,033 (3.8)</td><td class="xxxx-borders shading">54,613 (3.5)</td><td class="xxxx-borders shading">13,404 (6.6)</td><td class="xxxr-borders shading">34,016 (3.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">BNT162b2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">60,212 (2.3)</td><td class="xxxx-borders shading">40,203 (2.6)</td><td class="xxxx-borders shading">2,088 (1.0)</td><td class="xxxr-borders shading">17,921 (2.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">165,248 (6.2)</td><td class="xxxx-borders">114,050 (7.3)</td><td class="xxxx-borders">2,029 (1.0)</td><td class="xxxr-borders">49,169 (5.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">157,008 (5.9)</td><td class="xxxx-borders shading">98,853 (6.3)</td><td class="xxxx-borders shading">2,291 (1.1)</td><td class="xxxr-borders shading">55,864 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">34,081 (1.3)</td><td class="xxxx-borders">18,168 (1.2)</td><td class="xxxx-borders">343 (0.2)</td><td class="xxxr-borders">15,570 (1.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">31,958 (1.2)</td><td class="xxxx-borders">22,722 (1.4)</td><td class="xxxx-borders">845 (0.4)</td><td class="xxxr-borders">8,391 (0.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">76,935 (2.9)</td><td class="xxxx-borders shading">53,353 (3.4)</td><td class="xxxx-borders shading">417 (0.2)</td><td class="xxxr-borders shading">23,165 (2.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">22,745 (0.9)</td><td class="xxxx-borders">13,917 (0.9)</td><td class="xxxx-borders">92 (&lt;0.1)</td><td class="xxxr-borders">8,736 (1.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">80 (&lt;0.1)</td><td class="xxxx-borders shading">38 (&lt;0.1)</td><td class="xxxx-borders shading">1 (&lt;0.1)</td><td class="xxxr-borders shading">41 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">158 (&lt;0.1)</td><td class="xxxx-borders shading">107 (&lt;0.1)</td><td class="xxxx-borders shading">10 (&lt;0.1)</td><td class="xxxr-borders shading">41 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">444 (&lt;0.1)</td><td class="xxxx-borders">294 (&lt;0.1)</td><td class="xxxx-borders">19 (&lt;0.1)</td><td class="xxxr-borders">131 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">440 (&lt;0.1)</td><td class="xxxx-borders shading">264 (&lt;0.1)</td><td class="xxxx-borders shading">12 (&lt;0.1)</td><td class="xxxr-borders shading">164 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">84 (&lt;0.1)</td><td class="xxxx-borders">48 (&lt;0.1)</td><td class="xxxx-borders">0</td><td class="xxxr-borders">36 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">12,530 (0.5)</td><td class="xxxx-borders shading">7,038 (0.4)</td><td class="xxxx-borders shading">944 (0.5)</td><td class="xxxr-borders shading">4,548 (0.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">54,183 (2.0)</td><td class="xxxx-borders">29,759 (1.9)</td><td class="xxxx-borders">5,381 (2.6)</td><td class="xxxr-borders">19,043 (2.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders">9,001 (0.3)</td><td class="xxxx-borders">5,900 (0.4)</td><td class="xxxx-borders">466 (0.2)</td><td class="xxxr-borders">2,635 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">13,125 (0.5)</td><td class="xxxx-borders shading">9,516 (0.6)</td><td class="xxxx-borders shading">240 (0.1)</td><td class="xxxr-borders shading">3,369 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">29,912 (1.1)</td><td class="xxxx-borders">20,163 (1.3)</td><td class="xxxx-borders">981 (0.5)</td><td class="xxxr-borders">8,768 (1.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">91,754 (3.4)</td><td class="xxxx-borders shading">61,014 (3.9)</td><td class="xxxx-borders shading">5,562 (2.7)</td><td class="xxxr-borders shading">25,178 (2.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">243,470 (9.1)</td><td class="xxxx-borders">144,172 (9.2)</td><td class="xxxx-borders">17,077 (8.4)</td><td class="xxxr-borders">82,221 (9.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">138,085 (5.2)</td><td class="xxxx-borders shading">72,018 (4.6)</td><td class="xxxx-borders shading">10,348 (5.1)</td><td class="xxxr-borders shading">55,719 (6.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">94,139 (3.5)</td><td class="xxxx-borders">51,625 (3.3)</td><td class="xxxx-borders">8,531 (4.2)</td><td class="xxxr-borders">33,983 (3.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders">80,592 (3.0)</td><td class="xxxx-borders">44,166 (2.8)</td><td class="xxxx-borders">3,212 (1.6)</td><td class="xxxr-borders">33,214 (3.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">44,705 (1.7)</td><td class="xxxx-borders">29,459 (1.9)</td><td class="xxxx-borders">631 (0.3)</td><td class="xxxr-borders">14,615 (1.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">87,980 (3.3)</td><td class="xxxx-borders shading">64,874 (4.1)</td><td class="xxxx-borders shading">1,220 (0.6)</td><td class="xxxr-borders shading">21,886 (2.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">156,929 (5.9)</td><td class="xxxx-borders">110,306 (7.0)</td><td class="xxxx-borders">3,769 (1.8)</td><td class="xxxr-borders">42,854 (4.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">104,325 (3.9)</td><td class="xxxx-borders shading">61,534 (3.9)</td><td class="xxxx-borders shading">1,222 (0.6)</td><td class="xxxr-borders shading">41,569 (4.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">18,221 (0.7)</td><td class="xxxx-borders shading">12,718 (0.8)</td><td class="xxxx-borders shading">195 (0.1)</td><td class="xxxr-borders shading">5,308 (0.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">27,480 (1.0)</td><td class="xxxx-borders">20,045 (1.3)</td><td class="xxxx-borders">147 (0.1)</td><td class="xxxr-borders">7,288 (0.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">8,158 (0.3)</td><td class="xxxx-borders shading">5,311 (0.3)</td><td class="xxxx-borders shading">40 (&lt;0.1)</td><td class="xxxr-borders shading">2,807 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">87 (&lt;0.1)</td><td class="xxxx-borders">53 (&lt;0.1)</td><td class="xxxx-borders">1 (&lt;0.1)</td><td class="xxxr-borders">33 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">2,544 (0.1)</td><td class="xxxx-borders shading">1,429 (0.1)</td><td class="xxxx-borders shading">134 (0.1)</td><td class="xxxr-borders shading">981 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">5,656 (0.2)</td><td class="xxxx-borders">3,122 (0.2)</td><td class="xxxx-borders">448 (0.2)</td><td class="xxxr-borders">2,086 (0.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0 or 1 wk</td><td class="xxxx-borders">682 (&lt;0.1)</td><td class="xxxx-borders">467 (&lt;0.1)</td><td class="xxxx-borders">35 (&lt;0.1)</td><td class="xxxr-borders">180 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">1,104 (&lt;0.1)</td><td class="xxxx-borders shading">855 (0.1)</td><td class="xxxx-borders shading">13 (&lt;0.1)</td><td class="xxxr-borders shading">236 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">3,150 (0.1)</td><td class="xxxx-borders">2,286 (0.1)</td><td class="xxxx-borders">73 (&lt;0.1)</td><td class="xxxr-borders">791 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">14,324 (0.5)</td><td class="xxxx-borders shading">9,822 (0.6)</td><td class="xxxx-borders shading">674 (0.3)</td><td class="xxxr-borders shading">3,828 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">32,913 (1.2)</td><td class="xxxx-borders">20,017 (1.3)</td><td class="xxxx-borders">1,627 (0.8)</td><td class="xxxr-borders">11,269 (1.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">16,291 (0.6)</td><td class="xxxx-borders shading">8,961 (0.6)</td><td class="xxxx-borders shading">1,224 (0.6)</td><td class="xxxr-borders shading">6,106 (0.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">1,221 (&lt;0.1)</td><td class="xxxx-borders">474 (&lt;0.1)</td><td class="xxxx-borders">16 (&lt;0.1)</td><td class="xxxr-borders">731 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">Any: 0–6 days</td><td class="xxxx-borders">8,787 (0.3)</td><td class="xxxx-borders">4,745 (0.3)</td><td class="xxxx-borders">203 (0.1)</td><td class="xxxr-borders">3,839 (0.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">3,439 (0.1)</td><td class="xxxx-borders">2,031 (0.1)</td><td class="xxxx-borders">15 (&lt;0.1)</td><td class="xxxr-borders">1,393 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">3,410 (0.1)</td><td class="xxxx-borders shading">2,063 (0.1)</td><td class="xxxx-borders shading">8 (&lt;0.1)</td><td class="xxxr-borders shading">1,339 (0.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">36 (&lt;0.1)</td><td class="xxxx-borders">20 (&lt;0.1)</td><td class="xxxx-borders">0</td><td class="xxxr-borders">16 (&lt;0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">3 (&lt;0.1)</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">3 (&lt;0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">3,001 (0.1)</td><td class="xxxx-borders shading">1,851 (0.1)</td><td class="xxxx-borders shading">14 (&lt;0.1)</td><td class="xxxr-borders shading">1,136 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">3,067 (0.1)</td><td class="xxxx-borders">1,913 (0.1)</td><td class="xxxx-borders">5 (&lt;0.1)</td><td class="xxxr-borders">1,149 (0.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xbxx-borders shading">11 (&lt;0.1)</td><td class="xbxx-borders shading">4 (&lt;0.1)</td><td class="xbxx-borders shading">0</td><td class="xbxr-borders shading">7 (&lt;0.1)</td></tr></tbody></table></div></a><figcaption>Vaccination Status of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.</figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t2"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t3"><figure class="table"><a class="open-in-viewer" href="#t3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t3.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2119451/asset/6455aa8a-43e5-4270-a78a-5615cfed371f/assets/images/large/nejmoa2119451_t3.jpg" height="3438" width="1266" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Vaccination Status, Dose, and Interval after Vaccination</th><th class="txxx-borders">Test-Negative Status</th><th class="txxx-borders" colspan="2"><span>Delta Variant</span></th><th class="txxr-borders" colspan="2"><span>Omicron Variant</span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">Controls</th><th class="xxxx-borders">Case Participants</th><th class="xxxx-borders">Vaccine Effectiveness (95% CI)<a href="#core-t3fn2" role="doc-noteref">†</a></th><th class="xxxx-borders">Case Participants</th><th class="xxxr-borders">Vaccine Effectiveness (95% CI)<a href="#core-t3fn2" role="doc-noteref">†</a></th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders">no.</th><th class="xxxx-borders">no.</th><th class="xxxx-borders">%</th><th class="xxxx-borders">no.</th><th class="xxxr-borders">%</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders shading" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders shading">107,238</td><td class="xxxx-borders shading">36,369</td><td class="xxxx-borders shading">Reference</td><td class="xxxx-borders shading">101,109</td><td class="xxxr-borders shading">Reference</td></tr><tr data-type="row"><td class="xxlx-borders">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">0–3 wk</td><td class="xxxx-borders">33</td><td class="xxxx-borders">8</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">23</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥4 wk</td><td class="xxxx-borders shading">8,470</td><td class="xxxx-borders shading">2,133</td><td class="xxxx-borders shading">42.9 (39.8 to 45.9)</td><td class="xxxx-borders shading">5,547</td><td class="xxxr-borders shading">17.7 (14.3 to 21.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">476</td><td class="xxxx-borders shading">28</td><td class="xxxx-borders shading">82.8 (74.5 to 88.4)</td><td class="xxxx-borders shading">236</td><td class="xxxr-borders shading">48.9 (39.2 to 57.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">894</td><td class="xxxx-borders">85</td><td class="xxxx-borders">76.5 (70.3 to 81.5)</td><td class="xxxx-borders">505</td><td class="xxxr-borders">33.7 (25.0 to 41.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">10–14 wk</td><td class="xxxx-borders shading">1,659</td><td class="xxxx-borders shading">274</td><td class="xxxx-borders shading">69.2 (64.7 to 73.1)</td><td class="xxxx-borders shading">767</td><td class="xxxr-borders shading">28.6 (20.9 to 35.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">15–19 wk</td><td class="xxxx-borders">10,788</td><td class="xxxx-borders">4,013</td><td class="xxxx-borders">53.6 (51.6 to 55.5)</td><td class="xxxx-borders">2,974</td><td class="xxxr-borders">17.8 (13.4 to 21.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">20–24 wk</td><td class="xxxx-borders shading">68,757</td><td class="xxxx-borders shading">29,100</td><td class="xxxx-borders shading">47.4 (46.2 to 48.5)</td><td class="xxxx-borders shading">23,122</td><td class="xxxr-borders shading">4.0 (1.9 to 6.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥25 wk</td><td class="xxxx-borders">147,721</td><td class="xxxx-borders">46,103</td><td class="xxxx-borders">43.5 (42.4 to 44.5)</td><td class="xxxx-borders">98,970</td><td class="xxxr-borders">−2.7 (−4.2 to −1.2)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Booster dose</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">BNT162b2</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">40,203</td><td class="xxxx-borders shading">2,088</td><td class="xxxx-borders shading">88.7 (88.1 to 89.2)</td><td class="xxxx-borders shading">17,921</td><td class="xxxr-borders shading">58.8 (57.8 to 59.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">114,050</td><td class="xxxx-borders">2,029</td><td class="xxxx-borders">95.4 (95.1 to 95.6)</td><td class="xxxx-borders">49,169</td><td class="xxxr-borders">62.4 (61.8 to 63.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">98,853</td><td class="xxxx-borders shading">2,291</td><td class="xxxx-borders shading">92.6 (92.2 to 92.9)</td><td class="xxxx-borders shading">55,864</td><td class="xxxr-borders shading">52.9 (52.1 to 53.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">18,168</td><td class="xxxx-borders">343</td><td class="xxxx-borders">88.1 (86.7 to 89.3)</td><td class="xxxx-borders">15,570</td><td class="xxxr-borders">39.6 (38.0 to 41.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">22,722</td><td class="xxxx-borders">845</td><td class="xxxx-borders">91.5 (90.9 to 92.1)</td><td class="xxxx-borders">8,391</td><td class="xxxr-borders">68.0 (67.0 to 68.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">53,353</td><td class="xxxx-borders shading">417</td><td class="xxxx-borders shading">97.0 (96.7 to 97.3)</td><td class="xxxx-borders shading">23,165</td><td class="xxxr-borders shading">70.1 (69.5 to 70.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">13,917</td><td class="xxxx-borders">92</td><td class="xxxx-borders">94.9 (93.8 to 95.9)</td><td class="xxxx-borders">8,736</td><td class="xxxr-borders">60.9 (59.7 to 62.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">38</td><td class="xxxx-borders shading">1</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">41</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">ChAdOx1 nCoV-19</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">107</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">77.1 (55.1 to 88.3)</td><td class="xxxx-borders shading">41</td><td class="xxxr-borders shading">57.7 (37.6 to 71.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">294</td><td class="xxxx-borders">19</td><td class="xxxx-borders">82.3 (71.3 to 89.0)</td><td class="xxxx-borders">131</td><td class="xxxr-borders">55.6 (44.4 to 64.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">264</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">83.3 (69.7 to 90.8)</td><td class="xxxx-borders shading">164</td><td class="xxxr-borders shading">46.7 (34.3 to 56.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">48</td><td class="xxxx-borders">0</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">36</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">7,038</td><td class="xxxx-borders shading">5381</td><td class="xxxx-borders shading">45.2 (43.3 to 47.1)</td><td class="xxxx-borders shading">4,548</td><td class="xxxr-borders shading">42.8 (40.3 to 45.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">29,759</td><td class="xxxx-borders">466</td><td class="xxxx-borders">72.3 (69.4 to 74.9)</td><td class="xxxx-borders">19,043</td><td class="xxxr-borders">31.5 (29.9 to 33.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">9,516</td><td class="xxxx-borders">240</td><td class="xxxx-borders">90.9 (89.6 to 92.0)</td><td class="xxxx-borders">3,369</td><td class="xxxr-borders">65.5 (63.9 to 67.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">20,163</td><td class="xxxx-borders shading">981</td><td class="xxxx-borders shading">85.5 (84.5 to 86.5)</td><td class="xxxx-borders shading">8,768</td><td class="xxxr-borders shading">48.7 (47.1 to 50.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">61,014</td><td class="xxxx-borders">5,562</td><td class="xxxx-borders">78.7 (78.0 to 79.4)</td><td class="xxxx-borders">25,178</td><td class="xxxr-borders">30.1 (28.7 to 31.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">144,172</td><td class="xxxx-borders shading">17,077</td><td class="xxxx-borders shading">74.4 (73.8 to 74.9)</td><td class="xxxx-borders shading">82,221</td><td class="xxxr-borders shading">15.4 (14.2 to 16.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">72,018</td><td class="xxxx-borders">10,348</td><td class="xxxx-borders">67.4 (66.5 to 68.2)</td><td class="xxxx-borders">55,719</td><td class="xxxr-borders">11.5 (10.1 to 12.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">51,625</td><td class="xxxx-borders shading">8,531</td><td class="xxxx-borders shading">62.7 (61.6 to 63.7)</td><td class="xxxx-borders shading">33,983</td><td class="xxxr-borders shading">8.8 (7.0 to 10.5)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">29,459</td><td class="xxxx-borders">631</td><td class="xxxx-borders">92.3 (91.6 to 92.9)</td><td class="xxxx-borders">14,615</td><td class="xxxr-borders">66.9 (66.1 to 67.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">64,874</td><td class="xxxx-borders shading">1,220</td><td class="xxxx-borders shading">95.1 (94.8 to 95.4)</td><td class="xxxx-borders shading">21,886</td><td class="xxxr-borders shading">67.2 (66.5 to 67.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">110,306</td><td class="xxxx-borders">3,769</td><td class="xxxx-borders">91.8 (91.4 to 92.1)</td><td class="xxxx-borders">42,854</td><td class="xxxr-borders">55.0 (54.2 to 55.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">61,534</td><td class="xxxx-borders shading">1,222</td><td class="xxxx-borders shading">89.9 (89.2 to 90.5)</td><td class="xxxx-borders shading">41,569</td><td class="xxxr-borders shading">45.7 (44.7 to 46.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">12,718</td><td class="xxxx-borders shading">195</td><td class="xxxx-borders shading">93.7 (92.7 to 94.6)</td><td class="xxxx-borders shading">5,308</td><td class="xxxr-borders shading">74.0 (73.1 to 74.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">20,045</td><td class="xxxx-borders">147</td><td class="xxxx-borders">96.6 (96.0 to 97.1)</td><td class="xxxx-borders">7,288</td><td class="xxxr-borders">73.9 (73.1 to 74.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">5,311</td><td class="xxxx-borders shading">40</td><td class="xxxx-borders shading">94.9 (93.0 to 96.2)</td><td class="xxxx-borders shading">2,807</td><td class="xxxr-borders shading">64.4 (62.6 to 66.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">≥10 wk</td><td class="xxxx-borders">53</td><td class="xxxx-borders">1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">33</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging04 shading">mRNA-1273</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Dose 1</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">0–3 wk</td><td class="xxxx-borders shading">1,429</td><td class="xxxx-borders shading">134</td><td class="xxxx-borders shading">60.1 (51.8 to 66.9)</td><td class="xxxx-borders shading">981</td><td class="xxxr-borders shading">47.9 (43.1 to 52.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">≥4 wk</td><td class="xxxx-borders">3,122</td><td class="xxxx-borders">448</td><td class="xxxx-borders">57.4 (52.6 to 61.8)</td><td class="xxxx-borders">2,086</td><td class="xxxr-borders">31.9 (27.3 to 36.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14 shading">Dose 2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">855</td><td class="xxxx-borders">13</td><td class="xxxx-borders">94.5 (90.5 to 96.9)</td><td class="xxxx-borders">236</td><td class="xxxr-borders">75.1 (70.8 to 78.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">5–9 wk</td><td class="xxxx-borders shading">2,286</td><td class="xxxx-borders shading">73</td><td class="xxxx-borders shading">91.8 (89.6 to 93.6)</td><td class="xxxx-borders shading">791</td><td class="xxxr-borders shading">52.8 (48.2 to 57.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">10–14 wk</td><td class="xxxx-borders">9,822</td><td class="xxxx-borders">674</td><td class="xxxx-borders">84.1 (82.7 to 85.3)</td><td class="xxxx-borders">3,828</td><td class="xxxr-borders">35.6 (32.7 to 38.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">15–19 wk</td><td class="xxxx-borders shading">20,017</td><td class="xxxx-borders shading">1,627</td><td class="xxxx-borders shading">82.8 (81.8 to 83.7)</td><td class="xxxx-borders shading">11,269</td><td class="xxxr-borders shading">25.3 (23.2 to 27.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24" data-xml-align="left">20–24 wk</td><td class="xxxx-borders">8,961</td><td class="xxxx-borders">1,224</td><td class="xxxx-borders">76.2 (74.7 to 77.7)</td><td class="xxxx-borders">6,106</td><td class="xxxr-borders">15.0 (11.6 to 18.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging24 shading" data-xml-align="left">≥25 wk</td><td class="xxxx-borders shading">474</td><td class="xxxx-borders shading">16</td><td class="xxxx-borders shading">80.4 (67.3 to 88.2)</td><td class="xxxx-borders shading">731</td><td class="xxxr-borders shading">14.9 (3.9 to 24.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging14">Booster dose</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24 shading">BNT162b2</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">1 wk</td><td class="xxxx-borders">2,031</td><td class="xxxx-borders">15</td><td class="xxxx-borders">95.5 (92.5 to 97.3)</td><td class="xxxx-borders">1,393</td><td class="xxxr-borders">64.3 (61.7 to 66.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">2–4 wk</td><td class="xxxx-borders shading">2,063</td><td class="xxxx-borders shading">8</td><td class="xxxx-borders shading">94.7 (89.3 to 97.3)</td><td class="xxxx-borders shading">1,339</td><td class="xxxr-borders shading">64.9 (62.3 to 67.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">5–9 wk</td><td class="xxxx-borders">20</td><td class="xxxx-borders">0</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">16</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">≥10 wk</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">3</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging24">mRNA-1273</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34 shading" data-xml-align="left">1 wk</td><td class="xxxx-borders shading">1,851</td><td class="xxxx-borders shading">14</td><td class="xxxx-borders shading">95.3 (92.1 to 97.2)</td><td class="xxxx-borders shading">1,136</td><td class="xxxr-borders shading">68.1 (65.6 to 70.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging34" data-xml-align="left">2–4 wk</td><td class="xxxx-borders">1,913</td><td class="xxxx-borders">5</td><td class="xxxx-borders">96.4 (91.4 to 98.5)</td><td class="xxxx-borders">1,149</td><td class="xxxr-borders">66.3 (63.7 to 68.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging34 shading" data-xml-align="left">5–9 wk</td><td class="xbxx-borders shading">4</td><td class="xbxx-borders shading">0</td><td class="xbxx-borders shading">&nbsp;</td><td class="xbxx-borders shading">7</td><td class="xbxr-borders shading">&nbsp;</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t3fn1" role="paragraph" data-to-manipulate="true">CI denotes confidence interval.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t3fn2" role="paragraph" data-to-manipulate="true">To ensure reasonable precision, estimates are given if there are at least 10 case participants or 2000 controls.</div></div></div></figcaption></a><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants.<a href="#core-t3fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t3"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t3" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119451_t3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2119451</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern. November 26, 2021 (<a href="https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern">https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Classification+of+omicron+%28B.1.1.529%29%3A+SARS-CoV-2+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">European Centre for Disease Prevention and Control. Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (omicron) for the EU/EEA — first update. December 2, 2021 (<a href="https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Implications+of+the+further+emergence+and+spread+of+the+SARS-CoV-2+B.1.1.529+variant+of+concern+%28omicron%29+for+the+EU%2FEEA+%E2%80%94+first+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Cele S, Jackson L, Khoury DS, et al. SARS-CoV-2 omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. December 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3">https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+omicron+has+extensive+but+incomplete+escape+of+Pfizer+BNT162b2+elicited+neutralization+and+requires+ACE2+for+infection.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Wilhelm A, Widera M, Grikscheit K, et al. Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies. December 13, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v4">https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v4</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r4-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reduced+neutralization+of+SARS-CoV-2+omicron+variant+by+vaccine+sera+and+monoclonal+antibodies.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r4-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Huo J, Zhou D, et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. December 22, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2">https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r5-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron-B.1.1.529+leads+to+widespread+escape+from+neutralizing+antibody+responses.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r5-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r5-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] doses improved neutralizing activity. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] neutralization against the delta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. <em>Nat Med</em> 2021;27:1205-1211.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r6-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01377-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34002089/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000651469300002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing+antibody+levels+are+highly+predictive+of+immune+protection+from+symptomatic+SARS-CoV-2+infection.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=1205-1211&amp;doi=10.1038%2Fs41591-021-01377-8&amp;pmid=34002089" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r6-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] basis of these early laboratory findings. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r6-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] has been observed at a population level, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Addetia A, Crawford KHD, Dingens A, et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. <em>J Clin Microbiol</em> 2020;58(11):e02107-20-e02107-20.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JCM.02107-20" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32826322/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000582218400039" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing+antibodies+correlate+with+protection+from+SARS-CoV-2+in+humans+during+a+fishery+vessel+outbreak+with+a+high+attack+rate.&amp;publication_year=2020&amp;journal=J+Clin+Microbiol&amp;pages=e02107-20-e02107-20&amp;doi=10.1128%2FJCM.02107-20&amp;pmid=32826322" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Jeffery-Smith A, Rowland TAJ, Patel M, et al. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England. <em>Lancet Healthy Longev</em> 2021;2(12):e811-e819.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2666-7568(21)00253-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34873592/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reinfection+with+new+variants+of+SARS-CoV-2+after+natural+infection%3A+a+prospective+observational+cohort+in+13+care+homes+in+England.&amp;publication_year=2021&amp;journal=Lancet+Healthy+Longev&amp;pages=e811-e819&amp;doi=10.1016%2FS2666-7568%2821%2900253-1&amp;pmid=34873592" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_10_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. <em>Lancet</em> 2021;397:99-111.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(20)32661-1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33306989/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000607269000027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+ChAdOx1+nCoV-19+vaccine+%28AZD1222%29+against+SARS-CoV-2%3A+an+interim+analysis+of+four+randomised+controlled+trials+in+Brazil%2C+South+Africa%2C+and+the+UK.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=99-111&amp;doi=10.1016%2FS0140-6736%2820%2932661-1&amp;pmid=33306989" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_12_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. <em>BMJ</em> 2021;373:n1088-n1088.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/bmj.n1088" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33985964/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000652650700008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+Pfizer-BioNTech+and+Oxford-AstraZeneca+vaccines+on+covid-19+related+symptoms%2C+hospital+admissions%2C+and+mortality+in+older+adults+in+England%3A+test+negative+case-control+study.&amp;publication_year=2021&amp;journal=BMJ&amp;pages=n1088-n1088&amp;doi=10.1136%2Fbmj.n1088&amp;pmid=33985964" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. <em>Lancet</em> 2021;397:1725-1735.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00790-X" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33901423/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647813600027" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+coverage+in+health-care+workers+in+England+and+effectiveness+of+BNT162b2+mRNA+vaccine+against+infection+%28SIREN%29%3A+a+prospective%2C+multicentre%2C+cohort+study.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1725-1735&amp;doi=10.1016%2FS0140-6736%2821%2900790-X&amp;pmid=33901423" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — eight U.S. locations, December 2020–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:495-500.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7013e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33793460/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000636784900007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+vaccine+effectiveness+of+BNT162b2+and+mRNA-1273+COVID-19+vaccines+in+preventing+SARS-CoV-2+infection+among+health+care+personnel%2C+first+responders%2C+and+other+essential+and+frontline+workers+%E2%80%94+eight+U.S.+locations%2C+December+2020%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=495-500&amp;doi=10.15585%2Fmmwr.mm7013e3&amp;pmid=33793460" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. <em>N Engl J Med</em> 2021;384:1412-1423.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_16_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2101765&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640554500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+mRNA+Covid-19+vaccine+in+a+nationwide+mass+vaccination+setting.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1412-1423&amp;doi=10.1056%2FNEJMoa2101765&amp;pmid=33626250" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r16-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_17_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r16-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] than effectiveness against mild disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant. <em>N Engl J Med</em> 2021;385:585-594.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r17-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_18_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2108891&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34289274/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000675554200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Covid-19+vaccines+against+the+B.1.617.2+%28delta%29+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=585-594&amp;doi=10.1056%2FNEJMoa2108891&amp;pmid=34289274" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r17-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] in persons 18 years of age or older. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Pouwels KB, Pritchard E, Matthews PC, et al. Impact of delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. August 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1">https://www.medrxiv.org/content/10.1101/2021.08.18.21262237v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r19-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+delta+on+viral+burden+and+vaccine+effectiveness+against+new+SARS-CoV-2+infections+in+the+UK.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Andrews N, Tessier E, Stowe J, et al. Duration of protection against mild and severe disease by Covid-19 vaccines. <em>N Engl J Med</em> 2022;386:340-350.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_20_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2115481&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/35021002/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000741666000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Duration+of+protection+against+mild+and+severe+disease+by+Covid-19+vaccines.&amp;publication_year=2022&amp;journal=N+Engl+J+Med&amp;pages=340-350&amp;doi=10.1056%2FNEJMoa2115481&amp;pmid=35021002" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] with two Covid-19 vaccine doses. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] against both mild and severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] two doses of vaccine was well maintained. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] than effectiveness against mild disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r36" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the estimates against symptomatic disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] (e.g., age and clinical risk group). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Tada T, Zhou H, Dcosta BM, Samanovic MI, Mulligan MJ, Landau NR. Partial resistance of SARS-CoV-2 delta variants to vaccine-elicited antibodies and convalescent sera. <em>iScience</em> 2021;24(11):103341-103341.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.isci.2021.103341" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34723159/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000730163700011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Partial+resistance+of+SARS-CoV-2+delta+variants+to+vaccine-elicited+antibodies+and+convalescent+sera.&amp;publication_year=2021&amp;journal=iScience&amp;pages=103341-103341&amp;doi=10.1016%2Fj.isci.2021.103341&amp;pmid=34723159" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Goldberg Y, Mandel M, Bar-On YM, et al. Waning immunity of the BNT162b2 vaccine: a nationwide study from Israel. August 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1">https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Waning+immunity+of+the+BNT162b2+vaccine%3A+a+nationwide+study+from+Israel.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">Israel A, Merzon E, Schäffer AA, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. August 5, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1">https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Elapsed+time+since+BNT162b2+vaccine+and+risk+of+SARS-CoV-2+infection+in+a+large+cohort.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Mizrahi B, Lotan R, Kalkstein N, et al. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine: preliminary study. July 31, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1">https://www.medrxiv.org/content/10.1101/2021.07.29.21261317v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+SARS-CoV-2+breakthrough+infections+to+time-from-vaccine%3A+preliminary+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">Andrews N, Stowe J, Kirsebom F, Gower C, Ramsay M, Lopez Bernal J. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study. November 15, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.11.15.21266341v1">https://www.medrxiv.org/content/10.1101/2021.11.15.21266341v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+BNT162b2+%28Comirnaty%2C+Pfizer-BioNTech%29+COVID-19+booster+vaccine+against+covid-19+related+symptoms+in+England%3A+test+negative+case-control+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="core-r25" class="citations"><div class="citation"><div class="citation-content">Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. <em>N Engl J Med</em> 2021;385:1393-1400.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_26_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2114255&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34525275/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696036600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Protection+of+BNT162b2+vaccine+booster+against+Covid-19+in+Israel.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1393-1400&amp;doi=10.1056%2FNEJMoa2114255&amp;pmid=34525275" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="core-r26" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: omicron VOC-21NOV-01 (B.1.1.529) update on cases, S gene target failure and risk assessment. December 8, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r26-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+omicron+VOC-21NOV-01+%28B.1.1.529%29+update+on+cases%2C+S+gene+target+failure+and+risk+assessment&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r26-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] was apparent beginning in late November. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] target–positive result. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="core-r27" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. COVID-19 vaccine surveillance report: week 49. 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039677/Vaccine_surveillance_report_-_week_49.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039677/Vaccine_surveillance_report_-_week_49.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r27"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+surveillance+report%3A+week+49&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="core-r28" class="citations"><div class="citation"><div class="citation-content">Department of Health &amp; Social Care. JCVI advice on the UK vaccine response to the omicron variant. Independent report. November 29, 2021 (<a href="https://www.gov.uk/government/publications/uk-vaccine-response-to-the-omicron-variant-jcvi-advice/jcvi-advice-on-the-uk-vaccine-response-to-the-omicron-variant">https://www.gov.uk/government/publications/uk-vaccine-response-to-the-omicron-variant-jcvi-advice/jcvi-advice-on-the-uk-vaccine-response-to-the-omicron-variant</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=JCVI+advice+on+the+UK+vaccine+response+to+the+omicron+variant.+Independent+report&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="core-r29" class="citations"><div class="citation"><div class="citation-content">NHS England. National COVID-19 and flu vaccination programmes. 2021 (<a href="https://www.england.nhs.uk/contact-us/privacy-notice/national-flu-vaccination-programme/">https://www.england.nhs.uk/contact-us/privacy-notice/national-flu-vaccination-programme/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r29"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=National+COVID-19+and+flu+vaccination+programmes&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="core-r30" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. COVID-19: the green book, chapter 14a: coronavirus (COVID-19) vaccination information for public health professionals. 2020 (<a href="https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a">https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r30"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19%3A+the+green+book%2C+chapter+14a%3A+coronavirus+%28COVID-19%29+vaccination+information+for+public+health+professionals&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="core-r31" class="citations"><div class="citation"><div class="citation-content">NHS Digital. COVID-19 — high risk shielded patient list identification methodology. 2020 (<a href="https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology/rule-logic">https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology/rule-logic</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r31"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+%E2%80%94+high+risk+shielded+patient+list+identification+methodology&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="core-r32" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: variant of concern: omicron, VOC-21NOV-01 (B.1.1.529). Technical briefing 30. December 3, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038404/Technical_Briefing_30.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038404/Technical_Briefing_30.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+variant+of+concern%3A+omicron%2C+VOC-21NOV-01+%28B.1.1.529%29.+Technical+briefing+30&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="core-r33" class="citations"><div class="citation"><div class="citation-content">Public Health England, GitHub. Stardardised variant definitions. 2021 (<a href="https://github.com/phe-genomics/variant_definitions">https://github.com/phe-genomics/variant_definitions</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Stardardised+variant+definitions&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="core-r34" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 31. December 10, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1042367/technical_briefing-31-10-december-2021.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1042367/technical_briefing-31-10-december-2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r34-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England.+Technical+briefing+31&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r34-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r34-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] neutralization against the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] the limit of quantification in the assay. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r34-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] activity was observed after a booster dose. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="core-r35" class="citations"><div class="citation"><div class="citation-content">Goel RR, Painter MM, Apostolidis SA, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. <em>Science</em> 2021;374(6572):abm0829-abm0829.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r35-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm0829" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34648302/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000728578700050" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=mRNA+vaccines+induce+durable+immune+memory+to+SARS-CoV-2+and+variants+of+concern.&amp;publication_year=2021&amp;journal=Science&amp;pages=abm0829-abm0829&amp;doi=10.1126%2Fscience.abm0829&amp;pmid=34648302" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r35-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r35-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] limits progression to severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r35-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] in protection against SARS-CoV-2 variants. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="core-r36" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 34. January 14, 2022 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1048395/technical-briefing-34-14-january-2022.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England.+Technical+briefing+34&amp;publication_year=2022" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">37.</div><div id="core-r37" class="citations"><div class="citation"><div class="citation-content">Pavord S, Scully M, Hunt BJ, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. <em>N Engl J Med</em> 2021;385:1680-1689.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r37"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_38_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119451&amp;key=10.1056%2FNEJMoa2109908&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34379914/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685293800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+features+of+vaccine-induced+immune+thrombocytopenia+and+thrombosis.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1680-1689&amp;doi=10.1056%2FNEJMoa2109908&amp;pmid=34379914" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> Staten Island, New York</span></div><div><span>Radiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/872564/chair-of-radiology-staten-island-university-hospital-staten-island-new-york/?query=fjwp&amp;rid=3059">Chair of Radiology, Staten Island University Hospital Staten Island, New York</a></div></div><div class="nejm-widget_item"><div><span> Rhinebeck, New York</span></div><div><span>Geriatrics</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/887326/geriatrician-rhinebeck-ny-90-minutes-north-of-nyc-/?query=fjwp&amp;rid=12925">Geriatrician, Rhinebeck, NY (90 minutes North of NYC)</a></div></div><div class="nejm-widget_item"><div><span> New Hyde Park, New York</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/589186/board-certified-oncologist-or-hematologic-oncologist-new-hyde-park-ny/?query=fjwp&amp;rid=3059">Board-Certified Oncologist or Hematologic Oncologist - New Hyde Park, NY</a></div></div><div class="nejm-widget_item"><div><span> Bountiful, Utah</span></div><div><span>Psychiatry</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/891177/resident-and-fellowship-trained-psychiatrists-outpatient/?query=fjwf&amp;rid=377088">Resident and Fellowship trained Psychiatrists Outpatient</a></div></div><div class="nejm-widget_item"><div><span> Colorado Springs, Colorado</span></div><div><span>Primary Care</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/879327/primary-care-physician-optum-colorado-springs/?query=fjwf&amp;rid=220874">Primary Care Physician - Optum Colorado Springs</a></div></div><div class="nejm-widget_item"><div><span> Washington State</span></div><div><span>Family Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/890228/lifestyle-hospitalist-job-only-mon-thurs-avg-daily-census-of-3-washington/?query=fjwf&amp;rid=5263">Lifestyle Hospitalist Job | Only Mon-Thurs | Avg Daily Census of 3 | Washington</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128743&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejm%2Fregister%2Fnotablearticles2024%3Fpromo%3DONFQNAR4%26query%3Dcm-ra%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Dna24&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119451&amp;pubId=41283548&amp;placeholderId=101337&amp;productId=1007"><img src="/sda/128743/rightRail--notable24_001.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6cd48a141aecc-GRU">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6cd48a141aecc-GRU"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6cd48a141aecc-GRU"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$182830469$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$182830469$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$182830469$--></div></div><div class="mlt-body"><!--?lit$182830469$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$182830469$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$182830469$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$182830469$-->Jan 27, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2115481?query=recirc_Semantic" target="_self">Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines</a></div><div class="mlt-article-authors"><!--?lit$182830469$-->N. Andrews and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$182830469$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$182830469$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$182830469$-->Dec 16, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2105290?query=recirc_Semantic" target="_self">Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine</a></div><div class="mlt-article-authors"><!--?lit$182830469$-->A.R. Falsey and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$182830469$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$182830469$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$182830469$-->Mar 31, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2118691?query=recirc_Semantic" target="_self">Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection</a></div><div class="mlt-article-authors"><!--?lit$182830469$-->V. Hall and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$182830469$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$182830469$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$182830469$-->Aug 12, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2108891?query=recirc_Semantic" target="_self">Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant</a></div><div class="mlt-article-authors"><!--?lit$182830469$-->J. Lopez Bernal and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$182830469$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$182830469$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$182830469$-->Mar 10, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117128?query=recirc_Semantic" target="_self">Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina</a></div><div class="mlt-article-authors"><!--?lit$182830469$-->D.-Y. Lin and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2119451?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2119451" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119451.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2119451"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2117344" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMra2200869" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Increasing Incidence of Early-Onset Colorectal Cancer</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119451_f1.jpg"><img src="/cms/10.1056/NEJMoa2119451/asset/d2f1d981-336f-4a21-bbe3-ef0a852a2d2a/assets/images/large/nejmoa2119451_f1.jpg" height="3438" width="2456" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants, According to the Period after the Second and Booster Doses.</div><div class="notes"><div role="doc-footnote">B.1.617.2 is the delta variant, and B.1.1.529 the omicron variant, of the severe acute respiratory syndrome coronavirus 2. 𝙸 bars indicate 95% confidence intervals.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Characteristics of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t2" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 2</div><div class="fv__item__description"><figcaption>Vaccination Status of Persons Tested for SARS-CoV-2 in England, According to Test Positivity or Negativity and Variant.</figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t3" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 3</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Effectiveness against Symptomatic Disease Caused by the Delta and Omicron Variants.<a href="#fv-t3fn1" role="doc-noteref">*</a></div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/386/16" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 386 No. 16</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 21, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2118813" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">E. Israel and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 21, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2117344" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Ivosidenib and Azacitidine in <em>IDH1</em>-Mutated Acute Myeloid Leukemia</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">P. Montesinos and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 21, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2114833" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Calorie Restriction with or without Time-Restricted Eating in Weight Loss</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">D. Liu and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2119451%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119451&amp;pubId=41283548&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2119451%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119451&amp;pubId=41283548&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id0902713626904196" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6cd48a141aecc-GRU" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6cd48a141aecc-GRU" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6cd48a141aecc-GRU"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6cd48a141aecc-GRU"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6cd48a141aecc-GRU"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6cd48a141aecc-GRU"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6cd48a141aecc-GRU">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6cd48a141aecc-GRU">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6cd48a141aecc-GRU"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6cd48a141aecc-GRU"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6cd489814aecc',t:'MTc0OTUzNjgzNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6cd489814aecc&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script>
<div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>
        
        
    

<div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><zsj-obadejmjctui></zsj-obadejmjctui><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2119451?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><iframe name="captureIFrame_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-transactionid="m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" id="captureIFrame_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" target="captureIFrame_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="capture_screen"><input id="capture_signIn_js_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="js_version"><input id="capture_signIn_transactionId_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" type="hidden" class="capture_transactionId_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="capture_transactionId"><input id="capture_signIn_form_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="form"><input id="capture_signIn_flow_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="flow"><input id="capture_signIn_client_id_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="client_id"><input id="capture_signIn_redirect_uri_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="redirect_uri"><input id="capture_signIn_response_type_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="response_type"><input id="capture_signIn_flow_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="flow_version"><input id="capture_signIn_settings_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="settings_version"><input id="capture_signIn_locale_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="locale"><input id="capture_signIn_recaptcha_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_m3nu17bqhp8axv4imwezcqo9qmo7ny9bta8xmb57" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div></body></html>